var title_f8_57_9104="Uterine and vaginal development";
var content_f8_57_9104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schematic diagram of the formation of the uterus and vagina",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: At nine weeks, the uterine septum has disappeared. Middle panel: At 13 weeks, the sinovaginal bulbs have begun to grow out of the pelvic part of the urogenital sinus and form a solid plate. Right panel: In the newborn, the upper third of the vagina and the fornices are formed by vacuolization of the paramesonephric tissue and the lower-thirds of the vagina is formed by vacuolization of the sinovaginal bulbs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Langman, J, Medical Embryology, 4th ed, Williams &amp; Wilkins, Baltimore, 1981. p. 253.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9104=[""].join("\n");
var outline_f8_57_9104=null;
var title_f8_57_9105="Chancre";
var content_f8_57_9105=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chancre",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from&nbsp;Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9105=[""].join("\n");
var outline_f8_57_9105=null;
var title_f8_57_9106="Acute bronchitis in adults";
var content_f8_57_9106=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Acute bronchitis in adults (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/57/9106/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9106/contributors\" id=\"au148\">",
"       Thomas M File, Jr, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/57/9106/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9106/contributors\" id=\"se2060\">",
"       Daniel J Sexton, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/57/9106/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9106/contributors\" id=\"de8761\">",
"       Fenny H Lin, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?8/57/9106?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      BRONCHITIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Bronchitis develops when there is swelling and irritation of the bronchi, the large tubes that carry air to the lungs (",
"     <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"      figure 1",
"     </a>",
"     ). There are two types of bronchitis: acute (sudden onset) and chronic (long-standing).",
"    </p>",
"    <p>",
"     Acute bronchitis often occurs with a viral infection, such as the common cold, and is sometimes called a \"chest cold&rdquo;. The most common symptom of acute bronchitis is a nagging cough. Treatment of acute bronchitis usually involves treating the symptoms, such as sore throat and congestion. Antibiotics do not help to eliminate acute bronchitis caused by a virus. Antiviral agents are useful in some cases of acute bronchitis due to influenza, but there are no antiviral agents for other forms of viral bronchitis.",
"    </p>",
"    <p>",
"     This article will review the causes, symptoms, diagnosis, and treatment of acute bronchitis. Articles that discuss the common cold and sore throat are also available. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=see_link\">",
"      \"Patient information: The common cold in adults (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/15/36082?source=see_link\">",
"      \"Patient information: Sore throat in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Chronic bronchitis is discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=see_link\">",
"      \"Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)\"",
"     </a>",
"     .) More detailed information about acute bronchitis is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29289?source=see_link\">",
"      \"Acute bronchitis in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      BRONCHITIS CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Most cases of bronchitis are caused by a viral infection of the upper airways, such as the common cold or the flu. Less commonly, a bacterium called Bordetella pertussis, which causes pertussis (whooping cough), is the cause. (See",
"     <a class=\"local\" href=\"#H10\">",
"      'Whooping cough'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      BRONCHITIS SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     The most common symptoms of acute bronchitis include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       A persistent cough; this may last 10 to 20 days",
"      </li>",
"      <li>",
"       Some people cough up mucus, which may be clear, yellow, or green in color",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Fever is not common in people with acute bronchitis. However, having a fever can be a sign of another condition, such as the flu or pneumonia. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"      \"Patient information: Influenza symptoms and treatment (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=see_link\">",
"      \"Patient information: Pneumonia in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Conditions with similar features",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are other conditions that have symptoms similar to those of acute bronchitis.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Chronic cough &mdash; A persistent cough that lasts more than eight weeks is considered a chronic cough, which is discussed in detail elsewhere. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?27/34/28195?source=see_link\">",
"        \"Patient information: Chronic cough in adults (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Chronic bronchitis &mdash; Chronic bronchitis is defined as a cough that occurs on most days of the month for at least three months of the year during two consecutive years. This condition is discussed separately. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=see_link\">",
"        \"Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Pneumonia &mdash; Signs of pneumonia include fever and a fast heart and breathing rate. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=see_link\">",
"        \"Patient information: Pneumonia in adults (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Postnasal drip &mdash; Postnasal drip occurs when secretions drain from the sinuses into the throat. This can cause the throat to feel irritated, which causes you to feel like you need to clear your throat frequently. Postnasal drip can be caused by the common cold, allergies, sinusitis, or environmental irritants. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"        \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      BRONCHITIS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Most people who have a persistent cough after an upper respiratory infection (cold) do not need to see a healthcare provider. Diagnostic testing, such as x-rays, cultures, and blood tests, are not usually needed for people with acute bronchitis. However, testing may be recommended if your diagnosis is not clear based upon your examination or if another condition, such as pneumonia, is suspected.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      When to seek help",
"     </span>",
"     &nbsp;&mdash;&nbsp;You should call your healthcare provider if you have any of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Fever (temperature greater than 100.4&ordm; F or 38&ordm; C)",
"      </li>",
"      <li>",
"       A cough that lasts longer than 10 days",
"      </li>",
"      <li>",
"       Chest pain with coughing, difficulty breathing, or coughing up blood",
"      </li>",
"      <li>",
"       A barking cough that makes it hard to speak, especially if it persists",
"      </li>",
"      <li>",
"       Cough accompanied by unexplained weight loss",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     People who are older than 75 do not always have a fever or other concerning symptoms. If you are over 75 years and you have a persistent cough, you should call your clinician to determine if and when an office visit is recommended.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      BRONCHITIS TREATMENT",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Relief of symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;There is no specific treatment for bronchitis. There are a few treatments available for the common cold. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=see_link\">",
"      \"Patient information: The common cold in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A nonsteroidal antiinflammatory drug (ibuprofen, naproxen), aspirin, or acetaminophen (Tylenol&reg;) can help to relieve the pain of a sore throat or headache.",
"      </li>",
"      <li>",
"       Heated, humidified, air can improve symptoms of nasal congestion and runny nose, and has few to no side effects.",
"      </li>",
"      <li>",
"       Cough suppressant medications have not been shown to be helpful for most patients.",
"      </li>",
"      <li>",
"       Inhaler medications, commonly used for patients with asthma, are only helpful for those patients whose symptoms include wheezing or airflow obstruction and would require prescription.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antibiotics are",
"     <strong>",
"      NOT",
"     </strong>",
"     helpful for most people with bronchitis since the illness is typically caused by a virus. Antibiotics treat bacterial, not viral infections.",
"    </p>",
"    <p>",
"     Many people request antibiotics in the hopes that it will get rid of the cough, and some people even think that antibiotics have helped on previous occasions. However, there is no benefit of antibiotics for most cases of bronchitis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Whooping cough",
"     </span>",
"     &nbsp;&mdash;&nbsp;Whooping cough is caused by a bacterium, Bordetella pertussis. A vaccine is routinely given during childhood, and again during adolescence or adulthood, to reduce the risk of becoming infected with pertussis. However, the illness can still develop in those who were vaccinated. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"      \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Signs of whooping cough in adults include repeated \"spasms\" of severe coughing, sometimes followed by vomiting. Whooping cough often occurs as outbreaks, usually involving people who are incompletely immunized. If whooping cough is suspected, your healthcare provider may prescribe an antibiotic. Antibiotics will not help the cough, but can reduce the risk of spreading the infection to others. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=see_link\">",
"      \"Treatment and prevention of Bordetella pertussis infection in adolescents and adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      PREVENTING THE SPREAD OF ILLNESS",
"     </span>",
"    </p>",
"    <p>",
"     Hand washing is an essential and highly effective way to prevent the spread of infection. Wet your hands with water and plain soap and rub them together for 15 to 30 seconds. Pay special attention to the fingernails, between the fingers, and the wrists. Rinse your hands thoroughly, and dry with a single use towel.",
"    </p>",
"    <p>",
"     Alcohol-based hand rubs are a good alternative for disinfecting hands if a sink is not available. Spread the hand rub over the entire surface of your hands, fingers, and wrists until dry. You can use hand rubs repeatedly without irritating the skin or losing effectiveness. Hand rubs are available as a liquid or wipe in small, portable sizes that are easy to carry in a pocket or handbag. When a sink is available, you should wash visibly soiled hands with soap and water.",
"    </p>",
"    <p>",
"     Wash your hands before preparing food and eating; after going to the bathroom; and after coughing, blowing the nose, or sneezing. While it is not always possible to limit contact with people who are ill, avoid touching your eyes, nose, or mouth after direct contact, when possible.",
"    </p>",
"    <p>",
"     In addition, use a tissue to cover your mouth when sneezing or coughing. Throw away used tissues promptly and then wash your hands.",
"     <span class=\"nowrap\">",
"      Sneezing/coughing",
"     </span>",
"     into the sleeve of your clothing (at the inner elbow) is another way of containing sprays of saliva and secretions and does not contaminate your hands. Sneezing and coughing without covering your mouth can spread infection to anyone within six feet.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804547841\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12026121\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/28/24002?source=see_link\">",
"      Patient information: Acute bronchitis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12026138\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=see_link\">",
"      Patient information: The common cold in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/15/36082?source=see_link\">",
"      Patient information: Sore throat in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=see_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/12/35013?source=see_link\">",
"      Patient information: Influenza symptoms and treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/38/30308?source=see_link\">",
"      Patient information: Pneumonia in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/34/28195?source=see_link\">",
"      Patient information: Chronic cough in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29289?source=see_link\">",
"      Acute bronchitis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"      Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=see_link\">",
"      Management of infection in acute exacerbations of chronic obstructive pulmonary disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14727?source=see_link\">",
"      Etiology and evaluation of hemoptysis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=see_link\">",
"      Fluoroquinolones",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39271?source=see_link\">",
"      Treatment and prevention of Bordetella pertussis infection in adolescents and adults",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/bronchitis.html\">",
"        www.nlm.nih.gov/medlineplus/bronchitis.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.cdc.gov/getsmart/antibiotic-use/URI/bronchitis.html\">",
"        www.cdc.gov/getsmart/antibiotic-use/URI/bronchitis.html",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?8/57/9106/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 9, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?8/57/9106?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9106/abstract/1\">",
"      Snow V, Mottur-Pilson C, Gonzales R, et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9106/abstract/2\">",
"      Wenzel RP, Fowler AA 3rd. Clinical practice. Acute bronchitis. N Engl J Med 2006; 355:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9106/abstract/3\">",
"      Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:95S.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f8_57_9106=[""].join("\n");
var outline_f8_57_9106=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           BRONCHITIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           BRONCHITIS CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           BRONCHITIS SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           BRONCHITIS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           BRONCHITIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           PREVENTING THE SPREAD OF ILLNESS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\" title=\"figure 1\">",
"           Normal lung anatomy PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f8_57_9107="Axial CT one year";
var content_f8_57_9107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F55571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F55571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Axial CT one year",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 77-year-old female patient with biopsy-proven 1.8 cm left lower lobe adenocarcinoma (stage IA NSCLC) who was not considered a surgical candidate due to chronic obstructive pulmonary disease and cardiac risk. Axial CT image one-year following RFA shows that the treated area (arrow) continues to decrease in size and now appears as a focal area of volume loss within the left lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Schirmang, T, MD and Dupuy, D, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9107=[""].join("\n");
var outline_f8_57_9107=null;
var title_f8_57_9108="UV lesions IV";
var content_f8_57_9108=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urticarial vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 326px; height: 502px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urticarial patches with central ecchymosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9108=[""].join("\n");
var outline_f8_57_9108=null;
var title_f8_57_9109="Stages and architecture of normal sleep";
var content_f8_57_9109=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stages and architecture of normal sleep",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Mark R Pressman, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Robert C Basner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Ruth Benca, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9109/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9109/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/57/9109/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 17, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of normal sleep is uncertain, but it appears to be an active process during which the brain is involved in a variety of activities that are as complex as those occurring during wakefulness. Standards for the analysis of sleep were published in 1968 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/1\">",
"     1",
"    </a>",
"    ] and 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/2\">",
"     2",
"    </a>",
"    ]. Sleep laboratories accredited by the American Academy of Sleep Medicine (AASM) are required to use the 2007 standards, while sleep laboratories accredited by other organizations may continue to use the 1968 standards. In this review, we describe the stages and architecture of sleep according to the more recently published standards. Potential functions of normal sleep are also reviewed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SLEEP STAGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep is analyzed in 30 second epochs, each of which may be categorized as rapid eye movement (REM) sleep or non-rapid eye movement (NREM) sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Rapid eye movement (REM) sleep",
"    </span>",
"    &nbsp;&mdash;&nbsp;REM sleep describes a sleep stage that normally recurs every 90 to 120 minutes. It makes up about 20 to 25 percent of the total sleep time and occurs in four to five discrete episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/3\">",
"     3",
"    </a>",
"    ]. REM sleep is characterized by three main features [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A low voltage, fast frequency electroencephalogram (EEG) pattern that resembles an active, awake EEG pattern. This similarity is the reason that REM sleep is sometimes called paradoxical sleep.",
"     </li>",
"     <li>",
"      Rapid eye movements.",
"     </li>",
"     <li>",
"      An atonic electromyogram (EMG) indicating inactivity of all voluntary muscles, except the extraocular muscles. Atonia is the result of direct inhibition of alpha motor neurons.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    REM sleep can be classified as phasic REM sleep and tonic REM sleep. Phasic REM sleep is the portion of REM sleep during which there are phasic bursts of rapid eye movements, which may be associated with brief bursts of EMG activity (sometimes called twitching)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sudden increases in sympathetic activity. Tonic REM sleep is the portion of REM sleep that exists between the phasic bursts.",
"   </p>",
"   <p>",
"    REM sleep is a predominantly parasympathetic (ie, vagal) state. During phasic REM sleep, bursts of sympathetic nervous system activity occur, which may be associated with a sudden increase in arterial blood pressure, cardiac ischemia, cerebral ischemia, cardiac arrhythmias, heart rate,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    respiratory rate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Short central apneas, short central hypopneas, and long cardiac asystoles have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several sleep disorders may be related to abnormalities in REM sleep or the physiological events associated with REM sleep:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Narcolepsy &ndash; The role of REM sleep abnormalities in narcolepsy is described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=see_link\">",
"       \"Clinical features and diagnosis of narcolepsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Obstructive sleep apnea &ndash; REM-related voluntary muscle atonia may impair upper airway patency, exacerbating obstructive sleep apnea [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pulmonary disease &ndash; REM-related atonia extends to the intercostal and accessory muscles of breathing. This has potentially important implications for patients whose abnormal respiratory mechanics render them dependent upon their intercostal and accessory muscles to maintain an acceptable level of ventilation (eg, patients with chronic obstructive pulmonary disease, a chest wall disorder, or a neuromuscular disorder). During REM sleep, such patients may develop hypoventilation and oxyhemoglobin desaturation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      REM sleep behavior disorder &ndash; Individuals may act out their dreams if the muscle atonia of REM sleep is incomplete or absent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. Injuries to the patient or bed partner have been described.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    REM sleep may be delayed or suppressed by alcohol, sedative-hypnotic drugs, barbiturates and other anti-epileptics, beta antagonists, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs), and stimulants. Medications with prominent anti-cholinergic effects (eg, tricyclic antidepressants) may also delay or suppress REM sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/14\">",
"     14",
"    </a>",
"    ]. Conversely, REM sleep can be increased by withdrawal from alcohol, benzodiazepines, tricyclic depressants, or monoamine oxidase inhibitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Non-rapid eye movement (NREM) sleep",
"    </span>",
"    &nbsp;&mdash;&nbsp;NREM sleep is subdivided into stages. The original standards for sleep analysis recognized four stages of NREM sleep (N1, N2, N3, and N4) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the newer standards have incorporated stage N4 into stage N3, such that only three stages of NREM sleep are recognized by the newer standards (N1, N2, and N3) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Stage N1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stage N1 sleep is the transition from wakefulness to sleep. It is characterized by low amplitude, relatively fast EEG frequencies in the theta range (4 to 7 Hz). Stage N1 is the lightest stage of sleep; patients awakened from it typically do not perceive that they were actually asleep. Some sleep researchers do not consider stage N1 to be a true physiological sleep stage.",
"   </p>",
"   <p>",
"    Stage N1 sleep typically accounts for 2 to 5 percent of the total sleep time in young adults according to an analysis that used the original scoring standards. An increased proportion of stage N1 sleep typically suggests sleep fragmentation due to a sleep disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Stage N2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stage N2 sleep is sometimes called intermediate sleep. It is characterized by a slowing of the EEG frequency and an increase in the EEG amplitude. There are two distinct features of NREM sleep that appear for the first time on the EEG during this sleep stage: sleep spindles and K-complexes. Sleep spindles are transient, spindle-shaped features of the EEG that have a frequency of 11 to 16 Hz (most commonly 12 to 14 Hz) and a duration of &ge;0.5 seconds. They are most prominent at the vertex of the scalp. K-complexes are a well-delineated, negative, sharp wave immediately followed by a positive component that stand out from the background EEG and have a total duration of &ge;0.5 seconds. They usually have their maximal amplitude over the frontal regions.",
"   </p>",
"   <p>",
"    Stage N2 sleep typically accounts for 40 to 50 percent of the total sleep time according to an analysis that used the original scoring standards [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/15\">",
"     15",
"    </a>",
"    ]. &nbsp;Benzodiazepines increase stage N2 sleep at the expense of stage N3 sleep.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Stage N3",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stage N3 sleep is frequently referred to as deep sleep or slow wave sleep. It is characterized by low frequency (0.5 to 2 Hz), high amplitude delta EEG waves. Stage N3 sleep typically accounts for 20 percent of the total sleep time according to an analysis that used the original scoring standards [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SLEEP ARCHITECTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sleep stages occur in 90 to 120 minute cycles, with four to five cycles occurring during a typical night of sleep.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First half of the night: The first cycle consists of the individual passing from wakefulness, briefly into stage N1 sleep, and then into stages N2 and N3. Subsequent cycles consist of stage N2, stage N3, and REM sleep.",
"     </li>",
"     <li>",
"      Second half of the night: Stage N2 and REM sleep alternate. Wakefulness, stage N1, and stage N3 (ie, deep sleep) are usually absent during the second half of the night, but may occasionally occur.",
"     </li>",
"     <li>",
"      Physiologic functions (eg, reflexes, physiologic feedback, and control systems) may vary with the state of consciousness and different stages of sleep (",
"      <a class=\"graphic graphic_table graphicRef51422 \" href=\"UTD.htm?9/42/9900\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abnormalities of sleep architecture may suggest a sleep disorder. As an example, the occurrence of REM sleep earlier than 90 to 120 minutes following sleep onset suggests narcolepsy, depression, or REM-rebound following medication withdrawal. Sleep disorders increase the number of sleep stage changes and may completely disrupt the normal cycling of sleep. Abnormalities of sleep architecture may also result from irregular",
"    <span class=\"nowrap\">",
"     sleep/wake",
"    </span>",
"    organization (eg, prior sleep deprivation), coexisting conditions, withdrawal from certain medications (eg, tricyclic antidepressants, monoamine oxidase inhibitors), depression, or normal aging [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/17\">",
"     17",
"    </a>",
"    ]. With respect to aging, the amount of stage N3 sleep (deep sleep) decreases and the amount of stage N1 sleep (light sleep) increases as an individual gets older. As a result, the number of arousals and the amount of time spend in wakefulness increase. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17127?source=see_link\">",
"     \"The effects of medications on sleep quality and sleep architecture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     POTENTIAL FUNCTIONS OF SLEEP",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no agreement about the potential functions of sleep, or even whether sleep has more than one function. Numerous theories have been raised over the years, but none have been confirmed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The most prominent theory is called the &ldquo;Restorative Theory of Sleep&rdquo;, which states that some process during sleep restores tissue and prepares the body and the brain for the next day. This theory is supported by the observation that a night without sleep frequently leads to a poor performance the next day. The &ldquo;Adaptive Theory of Sleep&rdquo; proposes that sleep increases survival by immobilizing animals during the most dangerous time of the day, thereby decreasing their chances of becoming another animal's prey. Finally, the &ldquo;Energy Conservation Theory&rdquo; states that the function of sleep is to provide an interval during which there is a relatively reduced metabolism for the purpose of energy conservation.",
"   </p>",
"   <p>",
"    Just as the purpose of sleep in general is uncertain, the purposes of REM and NREM sleep are also uncertain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      REM sleep &ndash; It has been proposed that REM sleep may be important in memory consolidation [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/20\">",
"       20",
"      </a>",
"      ]. While its purpose is unclear, REM sleep appears to be essential. This is supported by animal studies that found that the animals died after several weeks of total deprivation of REM sleep [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/21\">",
"       21",
"      </a>",
"      ]. In humans, REM sleep rebounds to quantities that are higher than normal following REM sleep deprivation; this need to compensate for lost REM sleep suggests that insufficient REM sleep is detrimental [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      NREM sleep &ndash; It has been hypothesized that stage N3 sleep has a restorative function (ie, restoration of alertness and energy). This proposal is supported by the observations that the arousal threshold is highest during this stage and that stage N3 sleep is increased in athletes after significant physical effort [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9109/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27329060\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sleep is analyzed in 30 second epochs, each of which is categorized as rapid eye movement (REM) sleep or non-rapid eye movement (NREM) sleep. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sleep stages'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      REM sleep describes periods of relatively fast electroencephalogram (EEG) activity that recur every 90 to 120 minutes. It is characterized by three main features: a low voltage fast frequency EEG pattern, rapid eye movements, and an atonic electromyogram indicating inactivity of all voluntary muscles, except the extraocular muscles. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Rapid eye movement (REM) sleep'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two types of REM sleep are created when these features do not occur simultaneously: phasic REM sleep and tonic REM sleep. Phasic REM sleep is the portion of REM sleep during which there are phasic bursts of rapid eye movements, while tonic REM sleep is the portion of REM sleep that exists between the phasic bursts. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Rapid eye movement (REM) sleep'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NREM sleep is divided into three stages: N1, N2, and N3. A fourth stage, N4, was previously recognized only under older scoring standards, but newer standards have incorporated stage N4 into stage N3. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Non-rapid eye movement (NREM) sleep'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stage N1 sleep is the transition from wakefulness to sleep. It is characterized by relatively fast EEG frequencies in the theta range (4 to 7 Hz). Stage N1 is the lightest stage of sleep; patients awakened from it typically do not perceive that they were actually asleep. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Stage N1'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stage N2 sleep is sometimes called intermediate sleep. It is characterized by a slowing of the EEG frequency and an increase in the EEG amplitude. There are two distinct features of NREM sleep that appear for the first time on the EEG during this sleep stage: sleep spindles and K-complexes. Sleep spindles are transient, spindle-shaped features of the EEG that have a frequency of 11 to 16 Hz (most commonly 12 to 14 Hz) and a duration of &ge;0.5 seconds. K-complexes are a well-delineated, negative, sharp wave immediately followed by a positive component that stand out from the background EEG and have a total duration of &ge;0.5 seconds. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Stage N2'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stage N3 sleep is frequently referred to as deep sleep or slow wave sleep. It is characterized by low frequency (0.5 to 2 Hz), high amplitude delta EEG waves. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Stage N3'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sleep stages occur in cycles lasting 90 to 120 minutes each. Four to five cycles occur during a typical night of sleep. During the first half of the night, the individual typically passes from wakefulness, briefly into stage N1 sleep, and then into stages N2 and N3. Stages N2 and N3 reappear, after which REM sleep occurs for the first time. During the second half of the night, stage N2 and REM sleep alternate. Wakefulness, stage N1, and stage N3 (ie, deep sleep) are usually absent during the second half of the night, but may occasionally occur. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Sleep architecture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no agreement about the potential functions of sleep, or even whether sleep has more than one function. Numerous theories have been raised over the years, but none have been confirmed. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Potential functions of sleep'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rechtshaffen, A, Kales, A (Eds). A manual of standardized terminology and scoring system for sleep stages of human subjects. 204, U.S. Government Printing Offic; NIH, Washington, DC 1968.",
"    </li>",
"    <li>",
"     Iber, C, Ancoli-Israel, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specification, 1st, American Academy of Sleep Medicine, Westchester, IL 2007.",
"    </li>",
"    <li>",
"     Carskadon, MA, Dement, WC. Normal Human Sleep: An Overview. In: Principles and Practices of Sleep Medicine, Fifth, Kryger, MH, Roth, et al.  (Eds), Elsevier Saunders, St. Louis, MO 2011. p.16.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/4\">",
"      ASERINSKY E, KLEITMAN N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 1953; 118:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/5\">",
"      Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/6\">",
"      Hornyak M, Cejnar M, Elam M, et al. Sympathetic muscle nerve activity during sleep in man. Brain 1991; 114 ( Pt 3):1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/7\">",
"      Kawana F, Kasai T, Maeno K, et al. Atrioventricular block during the phasic events of REM sleep in a patient with severe obstructive sleep apnea syndrome. J Clin Sleep Med 2008; 4:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/8\">",
"      Osuna E, Pati&ntilde;o G. REM sleep-related complete heart block: is it a specific sleep-related disorder? Sleep Med 2006; 7:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/9\">",
"      Guilleminault C, Pool P, Motta J, Gillis AM. Sinus arrest during REM sleep in young adults. N Engl J Med 1984; 311:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/10\">",
"      Findley LJ, Wilhoit SC, Suratt PM. Apnea duration and hypoxemia during REM sleep in patients with obstructive sleep apnea. Chest 1985; 87:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/11\">",
"      Weitzenblum E, Chaouat A. Sleep and chronic obstructive pulmonary disease. Sleep Med Rev 2004; 8:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/12\">",
"      Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 1982; 239:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/13\">",
"      Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986; 9:293.",
"     </a>",
"    </li>",
"    <li>",
"     Hirshkowitz, M, Wilcox Rose, et al. Neurotransmitters, Neurochemistry, and the Clinical Pharmacology of Sleep. In: Sleep Disorders Medicine, 3rd ed, 2009. p.67-79.",
"    </li>",
"    <li>",
"     Pressman, MR. Primer of Polysomnogram Interpretation, Butterworth-Heinemann, Boston 2002.",
"    </li>",
"    <li>",
"     Physiology in Sleep, Orem, J, Barnes, CD (Eds), Academic Press, New York 1980.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/17\">",
"      Hirshkowitz, M, Moore, CA, Hamilton, CR, et al. Polysomnography of adults and elderly: Sleep architecture, respiration and leg movements. J Clin Neurophysiol 1992; 9:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/18\">",
"      Adam K, Oswald I. Sleep is for tissue restoration. J R Coll Physicians Lond 1977; 11:376.",
"     </a>",
"    </li>",
"    <li>",
"     Horne, J. Why We Sleep, Oxford University Press, Oxford 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/20\">",
"      Hobson JA. REM sleep and dreaming: towards a theory of protoconsciousness. Nat Rev Neurosci 2009; 10:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/21\">",
"      Rechtschaffen A, Bergmann BM, Everson CA, et al. Sleep deprivation in the rat: X. Integration and discussion of the findings. Sleep 1989; 12:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/22\">",
"      Endo T, Roth C, Landolt HP, et al. Selective REM sleep deprivation in humans: effects on sleep and sleep EEG. Am J Physiol 1998; 274:R1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9109/abstract/23\">",
"      Shapiro CM, Bortz R, Mitchell D, et al. Slow-wave sleep: a recovery period after exercise. Science 1981; 214:1253.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7710 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-218.189.88.190-7920B88E07-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9109=[""].join("\n");
var outline_f8_57_9109=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27329060\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SLEEP STAGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Rapid eye movement (REM) sleep",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Non-rapid eye movement (NREM) sleep",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Stage N1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Stage N2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Stage N3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SLEEP ARCHITECTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      POTENTIAL FUNCTIONS OF SLEEP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27329060\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/7710\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/7710|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/42/9900\" title=\"table 1\">",
"      Physiology in sleep",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25913?source=related_link\">",
"      Clinical features and diagnosis of narcolepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17127?source=related_link\">",
"      The effects of medications on sleep quality and sleep architecture",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_57_9110="Microcystic adnexal carcinoma invading bone";
var content_f8_57_9110=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Microcystic adnexal carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microcystic adnexal carcinoma can invade and destroy bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9110=[""].join("\n");
var outline_f8_57_9110=null;
var title_f8_57_9111="Hypertrophic lesion due to HSV-2 in an HIV-infected woman";
var content_f8_57_9111=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hypertrophic lesion due to HSV-2 in an HIV-infected woman",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Boothby M, Radcliffe K. An unusual vulval lesion in an HIV-infected woman. Int J STD AIDS 2007; 18:218. Copyright &copy; 2007 The Royal Society of Medicine Press. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9111=[""].join("\n");
var outline_f8_57_9111=null;
var title_f8_57_9112="Paroxysmal hemicrania: Treatment and prognosis";
var content_f8_57_9112=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Paroxysmal hemicrania: Treatment and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Manjit S Matharu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Anna S Cohen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9112/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9112/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/57/9112/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders characterized by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The TACs include cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite their common elements, the TACs differ in attack duration and frequency, as well as the response to therapy (",
"    <a class=\"graphic graphic_table graphicRef65541 \" href=\"UTD.htm?41/12/42188\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cluster headache has the longest attack duration and relatively low attack frequency",
"     </li>",
"     <li>",
"      Paroxysmal hemicrania has intermediate duration and intermediate attack frequency",
"     </li>",
"     <li>",
"      SUNCT has the shortest attack duration and the highest attack frequency",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The importance of recognizing these syndromes resides in their highly selective response to treatment. Hence, early diagnosis will often lead to appropriate treatment and rapid relief of pain. Paroxysmal hemicrania, unlike cluster headache and SUNCT, responds in a dramatic and absolute fashion to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    This topic will review the treatment and prognosis of paroxysmal hemicrania. Other clinical aspects of paroxysmal hemicrania are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other trigeminal autonomic cephalalgias are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14327?source=see_link\">",
"     \"Cluster headache: Epidemiology, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27174?source=see_link\">",
"     \"Pathophysiology of the trigeminal autonomic cephalalgias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28648?source=see_link\">",
"     \"SUNCT and SUNA headache syndromes: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of paroxysmal hemicrania is entirely prophylactic, as attacks are too short and intense for any acute oral treatment to be effective.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     Indomethacin",
"    </a>",
"    is the treatment of choice. Because it is rare, and because indomethacin is highly effective, there are no large prospective clinical trials evaluating therapy for PH.",
"   </p>",
"   <p>",
"    For patients who cannot tolerate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , one faces a difficult challenge. No other drug is consistently effective in paroxysmal hemicrania. Alternative drug therapies that may be useful for paroxysmal hemicrania are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDOMETHACIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, paroxysmal hemicrania responds completely to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link&amp;anchor=H15#H15\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\", section on 'Diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The existence of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    -insensitive paroxysmal hemicrania is controversial. However, there are reports of patients who have clinical symptoms consistent with paroxysmal hemicrania that do not respond to indomethacin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence supporting the effectiveness of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    comes mainly from observational case series [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/4,6-8\">",
"     4,6-8",
"    </a>",
"    ]. In the two largest series, the following observations were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 31 patients with paroxysmal hemicrania, 30 patients could tolerate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      , and all had a positive response [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective study with data for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      response in 40 patients diagnosed with chronic paroxysmal hemicrania, a consistent response to indomethacin was noted in 30 (75 percent). Of the 30 consistent responders, 24 had complete response, while six patients had a partial response. An inconsistent response was observed in 10 (25 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/4\">",
"       4",
"      </a>",
"      ]. While patients with an inconsistent response did not meet strict diagnostic criteria for paroxysmal hemicrania, the investigators noted that all had a headache phenotype that best fit with paroxysmal hemicrania rather than cluster headache.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dosage and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The starting dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    is 75 mg daily in three divided doses (ie, 25 mg three times a day). The indomethacin dose should be increased to 150 mg daily in three divided doses for 3 to 10 days if there is an incomplete response to the starting dose after three days. The dose should be further increased to 225 mg daily in three divided doses for 10 days for partial responders if the index of suspicion is high.",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    to confirm the diagnosis of paroxysmal hemicrania is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link&amp;anchor=H17#H17\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\", section on 'Indomethacin trial'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete resolution of the headache is typically prompt, usually occurring within one to two days of initiating the effective",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    dose. In patients who do not respond to indomethacin, the diagnosis of paroxysmal hemicrania should be reconsidered.",
"   </p>",
"   <p>",
"    The typical maintenance dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    is 25 to 100 mg daily. However, the effective maintenance dose can vary between 12.5 and 300 mg daily, depending on individual response and the fluctuation in attack severity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/9\">",
"     9",
"    </a>",
"    ]. Hence, dosage adjustments may be necessary to address the clinical fluctuations seen in paroxysmal hemicrania.",
"   </p>",
"   <p>",
"    Suspicion for a secondary cause of paroxysmal hemicrania should be raised in patients who need escalating doses or become refractory to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    treatment. Similarly, underlying pathology may be present in patients who require continuous high doses of indomethacin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/10\">",
"     10",
"    </a>",
"    ]. In such cases, we recommend careful diagnostic evaluation (or re-evaluation) for secondary causes, including brain imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link&amp;anchor=H20#H20\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\", section on 'Laboratory investigations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link&amp;anchor=H22#H22\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\", section on 'Secondary paroxysmal hemicrania'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients can expect sustained efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    treatment without developing tachyphylaxis, though about one-quarter develop gastrointestinal side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/11\">",
"     11",
"    </a>",
"    ]. The most common serious side effect of indomethacin is the development of peptic ulcers. Measures to prevent gastrointestinal side effects include testing and treating for Helicobacter pylori, and the use of gastroprotection with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    or proton pump inhibitors. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=see_link&amp;anchor=H10#H10\">",
"     \"NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity\", section on 'Prevention strategies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     Indomethacin",
"    </a>",
"    suppositories are occasionally helpful if gastric intolerance is a major problem, or when high doses, such as 300 mg daily, are required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Indomethacin discontinuation",
"    </span>",
"    &nbsp;&mdash;&nbsp;On discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , symptoms usually reappear within 12 hours to two weeks. During active headache cycles, however, skipping or even delaying doses may result in the prompt reoccurrence of the headache [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     Indomethacin",
"    </a>",
"    withdrawal strategies differ for patients with episodic and chronic forms of paroxysmal hemicrania.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with episodic paroxysmal hemicrania,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      should be given for slightly longer than the typical headache bout and then gradually tapered.",
"     </li>",
"     <li>",
"      In patients with chronic paroxysmal hemicrania, long-term treatment is usually necessary. However, long-lasting remissions have been reported in rare patients following cessation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      . Thus, we suggest an indomethacin drug withdrawal trial at least once every six months for patients with chronic paroxysmal hemicrania. This should be done by gradually tapering the dose of indomethacin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     The indomethacin effect",
"    </span>",
"    &nbsp;&mdash;&nbsp;What is the basis of the robust effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    in paroxysmal hemicrania? Though various hypotheses have been proposed to account for the efficacy of indomethacin in certain primary headache syndromes, its mechanism and site of action remain unclear.",
"   </p>",
"   <p>",
"    This engenders the question as to whether paroxysmal hemicrania (and hemicrania continua) always demonstrate a robust response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    and, therefore, can be classified on the basis of this specific treatment response. Though the current classification criteria require an absolute response to indomethacin for diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/3\">",
"     3",
"    </a>",
"    ], this is problematic for several reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The therapeutic response in patients with paroxysmal hemicrania or hemicrania continua is not exclusive to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      ; a variety of other medications have been reported to be effective.",
"     </li>",
"     <li>",
"      A response to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      is not specific to paroxysmal hemicrania or hemicrania continua; other primary headache syndromes also demonstrating a robust, albeit less consistent, response to indomethacin.",
"     </li>",
"     <li>",
"      Patients have been described who had the clinical phenotype of paroxysmal hemicrania or hemicrania continua but did not respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      . This raises the possibility that there is a subset of patients with the underlying biology and clinical phenotype of these syndromes who do not respond to indomethacin. Alternatively, the indomethacin-resistant cases do not represent true paroxysmal hemicrania or hemicrania continua if the mode of action of indomethacin involves interrupting the central pathogenetic mechanism of these syndromes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These considerations highlight the importance of understanding the mechanism of action of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    and the pathophysiological basis of these disorders.",
"   </p>",
"   <p>",
"    So what special feature of the pharmacology of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    accounts for its specific effect in these headache syndromes? Similar to other NSAIDs, indomethacin is a potent reversible inhibitor of prostaglandin-forming cyclooxygenase (COX). However, the mechanism of action of indomethacin in paroxysmal hemicrania and hemicrania continua seems to be independent of an effect on prostaglandin synthesis, since other NSAIDs or COX-2 inhibitors appear to have a poor, partial, or inconsistent effect in these disorders. Although indomethacin shows selectivity for COX-1 over COX-2 inhibition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=see_link\">",
"     piroxicam",
"    </a>",
"    are equally potent COX-1 inhibitors and yet do not have as robust a treatment effect on these disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The description of plasma protein extravasation into the dura mater of the rat after stimulation of the trigeminal ganglion led to the suggestion that this form of neurogenic inflammation may be partly responsible for the maintenance of head pain in primary neurovascular syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/15\">",
"     15",
"    </a>",
"    ]. Plasma protein extravasation can be blocked by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    , but also by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , triptans, ergots, gamma-aminobutyric acid agonists, glucocorticoids, and substance P antagonists, thereby making it unlikely as the mechanism of action of indomethacin in the indomethacin-responsive headache syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Moreover, the potent inhibition of plasma protein extravasation by triptans [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/19\">",
"     19",
"    </a>",
"    ] contrasts with its rather indifferent effect in paroxysmal hemicrania and hemicrania continua.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     Indomethacin",
"    </a>",
"    has also been shown to inhibit the production of nitric oxide&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/20\">",
"     20",
"    </a>",
"    ]. Nitric oxide plays a critical role in the neurogenic control of the cerebral circulation and has been implicated in the pathogenesis of primary neurovascular headaches, including the trigeminal autonomic cephalalgias [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/21\">",
"     21",
"    </a>",
"    ]. While other NSAIDS inhibit neurogenic induced vasodilation, an in vivo study in mice found that only indomethacin was able to inhibit nitric oxide-induced vasodilation, thus distinguishing it from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/22\">",
"     22",
"    </a>",
"    ]. As discussed separately, the pathophysiology of the trigeminal autonomic cephalalgias revolves around the trigeminal-autonomic reflex. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27174?source=see_link\">",
"     \"Pathophysiology of the trigeminal autonomic cephalalgias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The facial (cranial nerve VII) cranial parasympathetic outflow ganglia, sphenopalatine, and otic ganglia contain nitric oxide synthase, and nitric oxide generation is involved in the vasodilator responses of this system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/23\">",
"     23",
"    </a>",
"    ]. Nitric oxide is co-localized with vasoactive intestinal peptide [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], a neuropeptide that is markedly increased during an attack of paroxysmal hemicrania and normalized after treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/25\">",
"     25",
"    </a>",
"    ]. Thus indomethacin may antagonize one or more steps in the nitric oxide pathway and, in this way, exert its effect on disorders characterized by activation of the cranial parasympathetic system. However, if this is the mechanism and site of action of indomethacin then it remains unclear why it is ineffective in cluster headache and the SUNCT syndrome (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing). Another possibility that demands further study is that indomethacin may also act by inhibiting central nitrergic mechanisms.",
"   </p>",
"   <p>",
"    Several studies in animals, normal volunteers, and patients with traumatic brain edema have demonstrated that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    lowers intracranial pressure, improves cerebral perfusion pressure, and causes a substantial dose-related reduction of the cerebral blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. This mechanism of action of indomethacin is unlikely to be the mode of action in paroxysmal hemicrania and hemicrania continua; there is no pathophysiologic evidence that these headaches are caused by disordered intracranial pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ALTERNATIVE DRUG THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, patients who cannot tolerate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    face a difficult challenge, since no other drug is consistently effective in paroxysmal hemicrania. Alternative drug therapies that may have some benefit for paroxysmal hemicrania include nonsteroidal antiinflammatory drugs (NSAIDs) other than indomethacin, calcium channel blockers, and several miscellaneous agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other nonsteroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous other NSAIDs have been tried in paroxysmal hemicrania but none show the consistent and exquisite response provided by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/30\">",
"     30",
"    </a>",
"    ]. The NSAIDs that have been reported to be partially or completely effective, mainly in isolated cases, include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31-33\">",
"     31-33",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33\">",
"     33",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33-36\">",
"     33-36",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33,37\">",
"     33,37",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/36/43592?source=see_link\">",
"     ketoprofen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31\">",
"     31",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=see_link\">",
"     piroxicam",
"    </a>",
"    beta-cyclodextrin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited success in the treatment of paroxysmal hemicrania has been reported with the cyclooxygenase-2 (COX-2) inhibitors rofecoxib [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/39-41\">",
"     39-41",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/39,42\">",
"     39,42",
"    </a>",
"    ]. However, prolonged use of these agents is associated with an increased risk of myocardial infarction and stroke and rofecoxib was withdrawn from the market in 2004. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the risk of ischemic cardiovascular disease, the available COX-2 inhibitors should be prescribed only with great caution in paroxysmal hemicrania.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Calcium channel antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several case reports of patients with PH who had a partial or complete response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33,43-46\">",
"     33,43-46",
"    </a>",
"    ], and verapamil is generally considered the best alternative drug treatment to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    for PH [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other calcium channel antagonists that have been reported to be effective in paroxysmal hemicrania include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"     flunarizine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33,48\">",
"     33,48",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/61/42969?source=see_link\">",
"     nicardipine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these data, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    for patients with paroxysmal hemicrania who are unable to tolerate",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    . Similarly, we suggest verapamil for patients with a clinical phenotype of paroxysmal hemicrania who have an incomplete or poor response to an adequate trial of indomethacin. Verapamil is usually started at 160 to 240 mg daily in two divided doses. A lower starting dose of 80 mg daily in two divided doses is suggested for patients who are elderly or of small stature. The dose can be increased as needed and as tolerated up to 480 mg daily in three to four divided doses. Most responders require a dose of 240 to 320 mg daily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Miscellaneous drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other drugs reported to be partially or completely effective in PH, mainly in isolated cases, include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/49\">",
"     49",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31,35\">",
"     31,35",
"    </a>",
"    ], ergotamines [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31\">",
"     31",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/38/5736?source=see_link\">",
"     sumatriptan",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/33,50,51\">",
"     33,50,51",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several surgical approaches have been tried in paroxysmal hemicrania. They can be subdivided into two main groups: local blockades and invasive surgical procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Local blockades",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local anesthetic blockades of pericranial nerves, including the greater occipital nerve, supraorbital nerve, and lesser occipital nerve, have generally been ineffective for paroxysmal hemicrania, as have stellate ganglion blocks, sphenopalatine ganglion blocks, and cervical sympathetic blocks [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31,52\">",
"     31,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are two reports of complete response with local blockades. One was a patient with episodic paroxysmal hemicrania who consistently showed a complete response to greater occipital nerve blockade with a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    , but not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/53\">",
"     53",
"    </a>",
"    ]. Another case report described complete response to repetitive sympathetic chain block with a combination of bupivacaine and methylprednisolone introduced onto the C7 transverse process, but not with saline placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/54\">",
"     54",
"    </a>",
"    ]. This patient subsequently had a stellate ganglionectomy (sympathectomy) that rendered him pain-free, though follow-up was limited to 15 months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Invasive surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the exception of one report of benefit with stellate ganglionectomy discussed above [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/54\">",
"     54",
"    </a>",
"    ], invasive surgical procedures, including trigeminal sensory root section, infraorbital nerve section, superficial petrosal nerve section, and sphenopalatine ganglionectomy, have been ineffective [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/31,54\">",
"     31,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paroxysmal hemicrania is a rare syndrome, and there is a paucity of literature on its natural history and long-term prognosis. The available evidence suggests that it is a lifelong condition. Patients generally obtain sustained relief with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9112/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Indomethacin'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     Indomethacin",
"    </a>",
"    does not seem to alter the condition in the long-term, though a significant portion of patients can decrease the dose of indomethacin required to maintain a pain-free state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treatment of paroxysmal hemicrania is prophylactic, as attacks are too short and intense for any acute oral treatment to be effective. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pharmacologic treatments'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a paroxysmal hemicrania, we recommend treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Starting doses and dosage adjustments are discussed above. Gastrointestinal side effects are common with this therapy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indomethacin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       Indomethacin",
"      </a>",
"      withdrawal strategies differ for patients with episodic and chronic forms of paroxysmal hemicrania. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Indomethacin discontinuation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Though various hypotheses have been proposed to account for the efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      in certain primary headache syndromes, its mechanism and site of action remain unclear. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'The indomethacin effect'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with paroxysmal hemicrania who are unable to tolerate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      , and for patients with a clinical phenotype of paroxysmal hemicrania who have an incomplete or poor response to an adequate trial of indomethacin, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Reasonable alternatives include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and other NSAIDS, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/43/43705?source=see_link\">",
"       naproxen",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"       diclofenac",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Calcium channel antagonists'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Other nonsteroidal antiinflammatory drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With the exception of isolated case reports, local anesthetic blockades of pericranial nerves and invasive surgical procedures have been generally ineffective for the treatment of paroxysmal hemicrania. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The available evidence suggests that paroxysmal hemicrania is a lifelong condition. Patients generally obtain sustained relief with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      treatment. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Natural history and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/1\">",
"      Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997; 120 ( Pt 1):193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/2\">",
"      Goadsby PJ. Trigeminal autonomic cephalalgias. Pathophysiology and classification. Rev Neurol (Paris) 2005; 161:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/3\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/4\">",
"      Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache 2002; 42:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/5\">",
"      Fuad F, Jones NS. Paroxysmal hemicrania and cluster headache: two discrete entities or is there an overlap? Clin Otolaryngol Allied Sci 2002; 27:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/6\">",
"      Sjaastad O, Apfelbaum R, Caskey W, et al. Chronic paroxysmal hemicrania (CPH). The clinical manifestations. A review. Ups J Med Sci Suppl 1980; 31:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/7\">",
"      Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006; 59:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/8\">",
"      Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain 2008; 131:1142.",
"     </a>",
"    </li>",
"    <li>",
"     Sjaastad, O. Chronic paroxysmal hemicrania. In: Handbook of Clinical Neurology, Vol.48, Vinken, PJ, Bruyn, GW, Klawans, HL, Rose, FC (Eds). Elsevier Science, Amsterdam 1986. p.257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/10\">",
"      Sjaastad O, Stovner LJ, Stolt-Nielsen A, et al. CPH and hemicrania continua: requirements of high indomethacin dosages--an ominous sign? Headache 1995; 35:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/11\">",
"      Pareja JA, Caminero AB, Franco E, et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001; 21:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/12\">",
"      Matharu MS, Goadsby PJ. Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology. Curr Pain Headache Rep 2005; 9:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/13\">",
"      Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia 2001; 21:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/14\">",
"      Fr&ouml;lich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997; 18:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/15\">",
"      Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987; 7:4129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/16\">",
"      Buzzi MG, Sakas DE, Moskowitz MA. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989; 165:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/17\">",
"      Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc Res Tech 2001; 53:167.",
"     </a>",
"    </li>",
"    <li>",
"     Cutrer, FM, Limmroth, V, Waeber, C, et al. New targets for antimigraine drug development. In: Headache, Goadsby PJ, Silberstein SD (Eds), Butterworth-Heinemann, Philadelphia 1997. p.59.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/19\">",
"      Moskowitz MA, Cutrer FM. SUMATRIPTAN: a receptor-targeted treatment for migraine. Annu Rev Med 1993; 44:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/20\">",
"      Du ZY, Li XY. Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro. Int J Immunopharmacol 1999; 21:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/21\">",
"      Thomsen LL, Olesen J. Nitric oxide in primary headaches. Curr Opin Neurol 2001; 14:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/22\">",
"      Summ O, Andreou AP, Akerman S, Goadsby PJ. A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches. J Headache Pain 2010; 11:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/23\">",
"      Goadsby PJ, Uddman R, Edvinsson L. Cerebral vasodilatation in the cat involves nitric oxide from parasympathetic nerves. Brain Res 1996; 707:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/24\">",
"      Uddman R, Goadsby PJ, Jansen-Olesen I, Edvinsson L. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab 1999; 19:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/25\">",
"      Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation. Cephalalgia 1996; 16:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/26\">",
"      Slavik RS, Rhoney DH. Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients. Neurol Res 1999; 21:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/27\">",
"      Jensen K, Freundlich M, B&uuml;nemann L, et al. The effect of indomethacin upon cerebral blood flow in healthy volunteers. The influence of moderate hypoxia and hypercapnia. Acta Neurochir (Wien) 1993; 124:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/28\">",
"      Biestro AA, Alberti RA, Soca AE, et al. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report. J Neurosurg 1995; 83:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/29\">",
"      Jensen K, Ohrstr&ouml;m J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien) 1991; 108:116.",
"     </a>",
"    </li>",
"    <li>",
"     Sjaastad, O. Cluster Headache Syndrome. W. B. Saunders, London 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/31\">",
"      Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989; 29:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/32\">",
"      Kudrow DB, Kudrow L. Successful aspirin prophylaxis in a child with chronic paroxysmal hemicrania. Headache 1989; 29:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/33\">",
"      Evers S, Husstedt IW. Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996; 36:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/34\">",
"      Mateo I, Pascual J. Coexistence of chronic paroxysmal hemicrania and benign cough headache. Headache 1999; 39:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/35\">",
"      Hannerz J, Ericson K, Bergstrand G. Chronic paroxysmal hemicrania: orbital phlebography and steroid treatment. A case report. Cephalalgia 1987; 7:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/36\">",
"      Durko, A, Klimek, A. Naproxen in the treatment of chronic paroxysmal hemicrania. Cephalalgia 1987; 7:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/37\">",
"      Pradalier A, Dry J. [Chronic paroxysmal hemicrania. Treatment with indomethacin and diclofenac]. Therapie 1984; 39:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/38\">",
"      Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995; 35:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/39\">",
"      Siow HC. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 2004; 24:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/40\">",
"      Chakravarty A, Mukherjee A, Roy D. Trigeminal autonomic cephalgias and variants: clinical profile in Indian patients. Cephalalgia 2004; 24:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/41\">",
"      Lisotto C, Maggioni F, Mainardi F, Zanchin G. Rofecoxib for the treatment of chronic paroxysmal hemicrania. Cephalalgia 2003; 23:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/42\">",
"      Mathew NT, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000; 55:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/43\">",
"      Zidverc-Trajkovic J, Pavlovic AM, Mijajlovic M, et al. Cluster headache and paroxysmal hemicrania: differential diagnosis. Cephalalgia 2005; 25:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/44\">",
"      de Almeida DB, Cunali PA, Santos HL, et al. Chronic paroxysmal hemicrania in early childhood: case report. Cephalalgia 2004; 24:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/45\">",
"      Schlake HP, B&ouml;ttger IG, Grotemeyer KH, et al. Single photon emission computed tomography (SPECT) with 99mTc-HMPAO (hexamethyl propylenamino oxime) in chronic paroxysmal hemicrania--a case report. Cephalalgia 1990; 10:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/46\">",
"      Shabbir N, McAbee G. Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy. Headache 1994; 34:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/47\">",
"      May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006; 13:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/48\">",
"      Coria F, Claveria LE, Jimenez-Jimenez FJ, de Seijas EV. Episodic paroxysmal hemicrania responsive to calcium channel blockers. J Neurol Neurosurg Psychiatry 1992; 55:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/49\">",
"      Warner JS, Wamil AW, McLean MJ. Acetazolamide for the treatment of chronic paroxysmal hemicrania. Headache 1994; 34:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/50\">",
"      Pascual J, Quijano J. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan. J Neurol Neurosurg Psychiatry 1998; 65:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/51\">",
"      Hannerz J, Jogestrand T. Intracranial hypertension and sumatriptan efficacy in a case of chronic paroxysmal hemicrania which became bilateral. (The mechanism of indomethacin in CPH). Headache 1993; 33:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/52\">",
"      Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves. Funct Neurol 1997; 12:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/53\">",
"      Rossi P, Di Lorenzo G, Faroni J, Sauli E. Seasonal, extratrigeminal, episodic paroxysmal hemicrania successfully treated with single suboccipital steroid injections. Eur J Neurol 2005; 12:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9112/abstract/54\">",
"      Albertyn J, Barry R, Odendaal CL. Cluster headache and the sympathetic nerve. Headache 2004; 44:183.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3335 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-41B8DEA544-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9112=[""].join("\n");
var outline_f8_57_9112=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGIC TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDOMETHACIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dosage and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Indomethacin discontinuation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      The indomethacin effect",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ALTERNATIVE DRUG THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Calcium channel antagonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Miscellaneous drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Local blockades",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Invasive surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      NATURAL HISTORY AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/3335\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/3335|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/12/42188\" title=\"table 1\">",
"      Clinical features trigeminal autonomic cephalalgias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14327?source=related_link\">",
"      Cluster headache: Epidemiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38393?source=related_link\">",
"      NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=related_link\">",
"      Paroxysmal hemicrania: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27174?source=related_link\">",
"      Pathophysiology of the trigeminal autonomic cephalalgias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28648?source=related_link\">",
"      SUNCT and SUNA headache syndromes: Clinical features and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_57_9113="Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)";
var content_f8_57_9113=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Malcolm McDonald, PhD, FRACP, FRCPA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Michael J Richards, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Sally Roberts, MBChB, FRACP, FRCPA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9113/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/57/9113/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Until the advent of rapid air travel, Australia and New Zealand (Australasia) and the countries of the southwest Pacific (Oceania) were considered \"off the beaten track\" for travelers from North America and Europe (",
"    <a class=\"graphic graphic_figure graphicRef52073 \" href=\"UTD.htm?8/37/8787\">",
"     figure 1",
"    </a>",
"    ). However, there has been an almost 200 percent upsurge of overseas visitors to the region over the last decade [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/1\">",
"     1",
"    </a>",
"    ], with an increasing proportion of backpackers and adventurers visiting remote areas and staying in rudimentary accommodation. The region encompasses a remarkable diversity of geography, racial groups, cultures, technologic sophistication, and political systems.",
"   </p>",
"   <p>",
"    In an attempt to simplify the approach for travelers going to and returning from Australasia and Oceania, three separate divisions have been arbitrarily chosen, although it is acknowledged that considerable overlap exists:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Temperate Australia and New Zealand &mdash; Most Australians live in coastal temperate regions and enjoy sophisticated medical services with good communications. This is also the case for both the North and South Islands of New Zealand.",
"     </li>",
"     <li>",
"      Tropical and central Australia &mdash; The center of the continent and areas north of the tropic of Capricorn, called the \"far north,\" are sparsely populated. There are large distances between population centers, and travel routes often pass through relatively inhospitable country. This is a unique environment with distinct patterns of disease [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/2\">",
"       2",
"      </a>",
"      ] and fairly basic medical services.",
"     </li>",
"     <li>",
"      Oceania &mdash; The term Oceania includes the following countries in the southwest Pacific: Papua New Guinea (PNG), Cook Islands, Fiji, Guam, Kiribati, Marshall Islands, Nauru, New Caledonia, Niue, Northern Mariana Islands, Palau, Pitcairn, Samoa, American Samoa, Solomon Islands, Tahiti, Tokelau, Tonga, Tuvalu, Vanuatu, United States Trust Territory of the Pacific Islands, Wake Island, Wallis, and Futuna. Centers with busy tourist traffic often have adequate medical services, but many communities have only rudimentary services and are separated by long distances with irregular transport.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pretravel advice should be based on the latest published recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/3\">",
"     3",
"    </a>",
"    ] and, where appropriate, up-to-date local knowledge obtained from health authorities upon arrival. Initial assessment of travelers returning from Australasia and Oceania should be according to established principles [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. We will focus on those conditions unique to, or unusually prevalent, in this region. Particular emphasis will be placed on infectious diseases, envenomations and bites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TEMPERATE AUSTRALIA AND NEW ZEALAND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The important syndromes that can be acquired in this region are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef57488 \" href=\"UTD.htm?8/10/8366\">",
"     table 1",
"    </a>",
"    ). The risks of traveler's diarrhea, viral respiratory illness, food poisoning and common community illnesses are similar to those in developed countries in other parts of the world. Outbreaks of viral gastroenteritis, hepatitis A virus, and salmonellosis occur from time to time, although urban water supplies are usually safe. In New Zealand, the consumption of shellfish collected from areas where human effluent contamination may have occurred, such as marinas, should be avoided as outbreaks of gastrointestinal illnesses, such as shigellosis have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of invasive meningococcal disease in New Zealand was 2.4 cases per 100,000 population in 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/8\">",
"     8",
"    </a>",
"    ]. A nationwide vaccination program targeting persons &le;20 years of age has led to a significant decrease in the number of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/9\">",
"     9",
"    </a>",
"    ] and the predominantly serogroup B meningococcal disease epidemic has resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Arbovirus infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ross River virus (RRV) is the most common arbovirus infection in temperate Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/10\">",
"     10",
"    </a>",
"    ]. It is transmitted by mosquitoes of the Aedes and Culex species and is endemic in all Australian mainland states, with frequent summer outbreaks. RRV causes an acute febrile illness and rubella-like rash followed by a polyarthropathy and constitutional symptoms, which may last for many months. Barmah Forest virus has a similar epidemiology and causes a similar illness, but is usually less severe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41095?source=see_link\">",
"     \"Ross River virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other arboviruses are uncommon in temperate Australia and, at present, there are none of medical importance in New Zealand, although the mosquito vector for transmitting arboviral and other mosquito-borne diseases are established in New Zealand [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Rickettsial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Australian (Queensland) tick typhus is the most common rickettsial disease in Australia and occurs almost all the way down the east coast [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. It is caused by R. australis and transmitted by Ixodes ticks.",
"   </p>",
"   <p>",
"    This usually mild illness presents with the acute onset of fever, myalgia, and headache, usually followed, within one to 12 days, by the development of a maculopapular rash. Occasionally, the rash is petechial or vesicular. There is usually localized lymphadenopathy, and careful inspection may reveal a small eschar at the site of the tick bite. Campers and coastal bushwalkers are especially at risk.",
"   </p>",
"   <p>",
"    Other rickettsial infections are less common:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flinders Island tick typhus (R. honei) was first recognized on islands in Bass Strait and causes a milder illness. Infrequently it occurs on the southeastern Australian mainland. The reptile tick vector is Aponomona hydrosauri [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Scrub typhus, caused by Orientia tsutsugamushi, is a more severe and sometimes fatal illness [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/15\">",
"       15",
"      </a>",
"      ] that occurs in northern (tropical) Australia (see below) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=see_link\">",
"       \"Scrub typhus: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Murine typhus (R. typhi) is less common, but is endemic in southern Australia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/16\">",
"       16",
"      </a>",
"      ] and probably elsewhere, including New Zealand [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27796?source=see_link\">",
"       \"The epidemiology and clinical manifestations of murine typhus\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ehrlichiosis has not been reported in Australia or New Zealand.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Leptospirosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leptospirosis is endemic in parts of eastern rural Australia and New Zealand [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The most common occupational infection is due to L. borgpetersenii serovar hardjo associated with the dairy and beef industries. Tourists may be at risk through the increasingly popular \"farm stay\" establishments and through fresh water exposure as white water rafters, canoeists and hikers. The clinical pattern is that of an acute flu-like illness, often accompanied by aseptic meningitis. &nbsp;Occasionally, leptospirosis causes severe respiratory distress [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43879?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other infections occur infrequently in travelers to this region.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Q fever occurs widely in Australia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/21\">",
"       21",
"      </a>",
"      ] but is mainly associated with the livestock and meat industries and rarely affects travelers. Q fever is not seen in New Zealand [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Australia was declared free of bovine brucellosis in 1989 and now most cases result from B. suis following contact with feral pigs [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/23\">",
"       23",
"      </a>",
"      ]. In Queensland shooting or dogging feral pigs is a recreational and tourist activity, with slaughtering of pigs in the field. A case of pig-associated brucellosis was reported in New Zealand, but further investigation has found that the isolate was related to a marine isolate of Brucella [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/24\">",
"       24",
"      </a>",
"      ]. New Zealand livestock remains free of zoonotic Brucella (Mackereth, G, Investigation and Diagnostic Centre for Biosecurity New Zealand, Ministry of Agriculture and Fisheries, 2006, personal communication).",
"     </li>",
"     <li>",
"      Psittacosis is more common in southern Australian states with occasional outbreaks.",
"     </li>",
"     <li>",
"      Mycobacterial disease is relatively infrequent. Australian strains of M. tuberculosis are usually sensitive to all major antituberculosis agents. Rarely, M. ulcerans causes localized chronic progressive skin ulceration; the diagnosis of this condition is made by PCR or biopsy and culture. The risk to travelers is small. Infections have been predominantly reported from coastal areas in southern Victoria between Gippsland and the Bellarine peninsula, and Queensland near Cairns and Rockhampton.",
"     </li>",
"     <li>",
"      The presence of endemic Lyme disease and plague has not been proven in Australia or New Zealand.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Envenomations and bites",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Snakes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Australia and Papua New Guinea are host to a variety of extremely venomous snakes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/25\">",
"     25",
"    </a>",
"    ], whereas New Zealand and many Pacific islands seem to be spared. The most commonly encountered species are timid and will not become aggressive unless surprised or pursued. Travelers, especially those going to rural and wilderness areas, should treat all snakes with great respect, use appropriate footwear, and have some knowledge about first aid measures for snakebite, including the principle of immobilizing a bitten limb. Appropriate antivenom is generally available at regional hospitals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Spiders",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several venomous spiders of concern; these include the Red-back, which is common but the bite is rarely fatal, and the Sydney funnel-web, which is very limited in distribution. Antivenoms are available [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/16/24839?source=see_link\">",
"     \"Approach to the patient with a suspected spider bite: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Ticks",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to tick-borne infection, human tick paralysis due to Ixodes holocyclus is occasionally reported, especially along the Australian east coast [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/27\">",
"     27",
"    </a>",
"    ]. Antitoxin is also available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Sea creatures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sting rays, sharks and jellyfish may cause injury to swimmers and waders in summer months, but beaches are reasonably safe, especially those patrolled by lifeguards. The blue-ringed octopus (Hapalochlaena maculosa) is found in Papua New Guinea and all around Australia; it lives in rock pools and around shallow reefs and can change color to match its surroundings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/28\">",
"     28",
"    </a>",
"    ]. The creature is small enough to fit into the palm of a hand and displays vivid blue rings on its skin, especially when agitated. As such, it is attractive to both curious children and adult tourists alike. The venomous bite is initially thought to be trivial; symptoms begin within 10 to 20 minutes including paresthesias, muscular weakness, vomiting, and respiratory arrest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Sandflies and midges",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sandfly and midge bites cause local induration and may become secondarily infected. They are a special problem in the coastal regions of parts of New Zealand and Australia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most of the year, the climate in temperate Australia and New Zealand is comfortable, but the summer sun can be particularly intense and precautions should be taken to prevent sunburn.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TROPICAL AND CENTRAL AUSTRALIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the infections and other problems mentioned above, risks for the traveler in a tropical climate include insect bites and sores which may become infected with Streptococcus pyogenes (group A Streptococcus) or Staphylococcus aureus, and dermatophytoses. Travelers are discouraged from going outdoors in bare feet. Hookworm is endemic in some communities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Dengue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dengue occurs in the Torres Strait [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/10\">",
"     10",
"    </a>",
"    ]. Outbreaks of serotypes 1, 2 and 3 have been reported, although hemorrhagic fever is rare. Travelers may be at risk during epidemic periods. Aedes aegypti tends to also bite in the daytime; as a result, 24 hour mosquito protection measures are recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36953?source=see_link\">",
"     \"Pathogenesis of dengue virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other arboviral infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Japanese encephalitis has been reported on the Australian mainland [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/29\">",
"     29",
"    </a>",
"    ], and it has also been a problem on the Torres Strait islands [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Other important arboviruses in the region include Ross River Virus and Kunjin (closely related to West Nile virus); Murray Valley (Australian) encephalitis is enzootic in the far north of Australia and causes infrequent outbreaks in southern states [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41095?source=see_link\">",
"     \"Ross River virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At present, Japanese encephalitis vaccination is not recommended for visitors to the region. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=see_link&amp;anchor=H12#H12\">",
"     \"Arthropod-borne encephalitides\", section on 'Japanese encephalitis virus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Rickettsial and brucella infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Australian (Queensland) tick typhus and scrub typhus are the most important tick-borne diseases in northern Australia. Scrub typhus has an unusual pattern of distribution with regional foci of high risk, such as the area just south of Darwin in the Northern Territory. Q fever also occurs in the region, while brucellosis, due to B. suis, is confined to western Queensland and mainly occurs in people who hunt wild pigs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Melioidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melioidosis, caused by the soil saprophyte Burkholderia pseudomallei, is endemic to the Northern Territory, far north Queensland, and northern Western Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/32\">",
"     32",
"    </a>",
"    ]. It is now an important cause of severe community-acquired pneumonia in the far north of Australia. Infection in travelers has occurred and the risk is highest in the area during the monsoon. Risk factors include alcohol intoxication, diabetes mellitus and chronic renal disease. Tourists occasionally become infected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39577?source=see_link\">",
"     \"Epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of melioidosis may not appear for many years after the traveler leaves the endemic area. Common presentations include fulminant pneumonia, fever, skin abscesses, visceral and prostatic abscesses, osteomyelitis, frontoparietal lobe abscess and brainstem encephalitis. It may also present as subacute or chronic pneumonia, causing cavitary apical disease that mimics tuberculosis. Awareness of possible melioidosis in travelers is particularly important because there may be a need for urgent empiric therapy, with an agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    , before the microbiologic diagnosis is confirmed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic meningitis, due to Angiostrongylus cantonensis, occurs along the Queensland coast [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/33\">",
"     33",
"    </a>",
"    ]. Several cases of human and equine morbillivirus infection were described in the 1990s [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/34\">",
"     34",
"    </a>",
"    ]; pneumonic and encephalitic forms were associated with high mortality but risk for travelers is low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25622?source=see_link\">",
"     \"Nipah and Hendra viral encephalitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Australia, New Zealand, and Oceania are free of rabies, human schistosomiasis and yellow fever. There have been two reported cases of fatal Lyssavirus encephalitis in Queensland [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/34\">",
"     34",
"    </a>",
"    ]. This virus appears to be carried by both insectivorous and fruit bats; thus, the handling of wild bats by visitors is strongly discouraged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Envenomations and bites",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Snakes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Snakes of the tropical region include the Western Brown Snake, the Death Adder and the Taipan, one of the most dangerous in the world [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/25\">",
"     25",
"    </a>",
"    ]. Sea snakes are common in the waters off tropical Australian and the Pacific nations; they are moderately venomous but their bite is rarely fatal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31431?source=see_link\">",
"     \"Principles of snake bite management worldwide\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Crocodiles",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most of northern Australia, swimming in coastal estuaries and rivers carries the risk of crocodile attack. Appropriate caution is advised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Sea creatures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of all jellyfish (Coelenterata) inhabiting the coastal waters of northern Australia, the box jellyfish (Chironex fleckeri) is probably the most dangerous. Waders and swimmers may run into the tentacles in shallow water from October through May [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/35\">",
"     35",
"    </a>",
"    ]. Severe local pain may be followed by apnea and cardiac arrest, sometimes in less than five minutes. Prompt first aid with CPR and administration of antivenom may be lifesaving. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/0/43016?source=see_link\">",
"     \"Jellyfish stings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other venomous jellyfish include the bluebottle (Physalia utriculus), Portuguese man-o'-war (Physalia physalis) and the Irukandji (Carukia barnesi) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/35\">",
"     35",
"    </a>",
"    ]. Stone fish, cone shells, sting rays and various spiny reef creatures also occasionally cause injury to unwary visitors, especially those without proper footwear. Ciguatera fish poisoning is dealt with in the next section (Oceania).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Travelers to central and northern Australia should be aware that distances are vast, roads may be difficult, temperatures are often severe, and water sparse. Every year, people perish in the \"outback\" despite all efforts to warn travelers of the potential hazards and to encourage proper planning [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/36\">",
"     36",
"    </a>",
"    ]. Furthermore, sophisticated medical care may not always be available outside the main cities. As a result, travelers with significant illness or debility wishing to visit wilderness areas should probably consider alternative travel plans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     OCEANIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of different types of infections can occur in travelers to Oceania. Traveler's diarrhea is a common problem, and most cases are presumably due to enteropathogenic E. coli. Other enteric pathogens include Shigella, Salmonella, and Entamoeba histolytica, and outbreaks of viral gastroenteritis occur from time to time. Enteric fever, due to S. paratyphi A or S. typhi, is sometimes seen. Penicillin-resistant Streptococcus pneumoniae is prevalent in PNG; this should be taken into account when travelers develop pneumonia or meningitis.",
"   </p>",
"   <p>",
"    Hepatitis A is common in Oceania, especially in the village setting and hepatitis B is endemic throughout the region [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/3\">",
"     3",
"    </a>",
"    ]. There are also high levels of sexually transmitted infections. HIV is now a major problem in Papua New Guinea (PNG) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/37\">",
"     37",
"    </a>",
"    ]; it is a relatively small, but growing problem in other countries of the region. Blood supplies are not guaranteed.",
"   </p>",
"   <p>",
"    Hookworm and Ascaris lumbricoides are endemic in the rural setting. Tropical skin infections may cause considerable morbidity and distress.",
"   </p>",
"   <p>",
"    Tourists commonly visit the region on cruise ships. As such, large groups of people are living in a confined space and person-to-person transmission of respiratory (eg, influenza) and gastrointestinal (eg, noroviruses) illnesses is a particular risk. Appropriate immunizations and frequent hand washing are important preventive measures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Malaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malaria is endemic in PNG, the Solomon Islands, and Vanuatu [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/3\">",
"     3",
"    </a>",
"    ], and is the greatest risk for travelers to these areas. Chloroquine-resistance in P. falciparum is widespread and relative resistance is also becoming a problem in P. vivax [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/39\">",
"     39",
"    </a>",
"    ]. The Chesson strain of P. vivax has reduced susceptibility to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/59/38837?source=see_link\">",
"     primaquine",
"    </a>",
"    and is common in the region. Post-treatment relapse is more likely unless higher doses or more prolonged courses of primaquine are used. This should be taken into account when assessing and treating febrile travelers who have returned from PNG, even 12 months after their visit.",
"   </p>",
"   <p>",
"    People intending to travel to endemic areas should be advised about primary protection measures in addition to receiving chemoprophylaxis. Sometimes conflicting advice is given from different advisory bodies, which may be a source of confusion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=see_link\">",
"     \"Prevention of malaria infection in travelers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prescribing clinicians are advised to consult the latest edition of Health Information for International Travel, CDC [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/41\">",
"       41",
"      </a>",
"      ]. Current first line recommendations include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/56/902?source=see_link\">",
"       atovaquone-proguanil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/21/17751?source=see_link\">",
"       mefloquine",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Other regimens may be available locally; in general, they are not recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No regimen is 100 percent effective. Self-treatment regimens are sometimes provided for people living for extended periods in remote areas of PNG, but should not be recommended to tourists and short term visitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Arboviral infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dengue is endemic in PNG and epidemics occur from time to time throughout most of Oceania [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/3,42,43\">",
"     3,42,43",
"    </a>",
"    ]. Dengue hemorrhagic fever is rare. For travelers arriving in, or returning to New Zealand, the most frequently implicated Oceania destinations for acquisition of Dengue fever in 2003 were Fiji and Tonga [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ross River virus also causes epidemics in most parts of the region and was reported in two Canadian travelers returning from Fiji in late 2003 and early 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/45\">",
"     45",
"    </a>",
"    ]. Murray Valley and Japanese B encephalitis have been mainly confined to PNG and Torres Strait [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/10,42\">",
"     10,42",
"    </a>",
"    ]. Chikungunya has not been observed in Oceania but is expected to occur given the nature of its geographic spread. Other arthropod-borne infections that can occur include scrub typhus in PNG, and filariasis, which is widespread but unlikely to pose a significant risk to travelers because of limited exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Eosinophilic meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection due to Angiostrongylus cantonensis (the rat lungworm) is an increasing problem for visitors to Oceania [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/33,46\">",
"     33,46",
"    </a>",
"    ], particularly backpackers, surfers and scuba divers who are less likely to be staying in western hotel-style accommodations. It can be acquired by eating contaminated leafy vegetables (in salads), infected snails and slugs (often inadvertently), and land crabs. One to three weeks later, dermatomal sensory paresthesias may herald the onset of meningitis. Motor symptoms are uncommon.",
"   </p>",
"   <p>",
"    The diagnosis is made on lumbar puncture, which reveals eosinophils in the cerebrospinal fluid. Treatment is symptomatic; the illness is usually self-limiting, although more severe forms do occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Other infections",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leptospirosis &mdash; Leptospirosis is common in the Southwest Pacific, especially in Vanuatu, Fiji and New Caledonia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/47\">",
"       47",
"      </a>",
"      ]. It is more common in rural areas, although travelers occasionally become infected [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/48\">",
"       48",
"      </a>",
"      ]. The disease may be severe with hepatic and renal involvement; sometimes pulmonary hemorrhage is a prominent feature.",
"     </li>",
"     <li>",
"      Cryptococcal disease &mdash; In PNG, Cryptococcus gattii infection occurs relatively more frequently than Cryptococcus neoformans, and is often associated with cryptococcoma [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Melioidosis &mdash; Melioidosis occurs in PNG, but may be less common than in northern Australia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/50\">",
"       50",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Melioidosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Coral injury &mdash; Local injury due to coral-related trauma may quickly become infected with marine or terrestrial bacteria. These infections often progress despite treatment with antibiotics because \"coral slime,\" a proteinaceous material, is introduced into the wound and acts as a foreign body [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/51\">",
"       51",
"      </a>",
"      ]. Thus, any significant laceration or graze sustained from coral should be carefully debrided and scrubbed with a brush; an anesthetic may be required. If infection does become established, it is unlike to resolve until proper scrubbing has been done.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Envenomations, toxins and bites",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Snakes and sea creatures",
"    </span>",
"    &nbsp;&mdash;&nbsp;PNG has several venomous snakes, including the Taipan. Sea snakes and other venomous marine risks are similar to those in tropical Australia. A major concern is lack of locally available antivenoms, even in major centers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Fish poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two common types of fish poisoning in the region [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Scombroid fish poisoning is due to decomposition of certain fish resulting in accumulation of histamine and related substances in the flesh [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/55\">",
"     55",
"    </a>",
"    ]. Symptoms begin soon after ingestion and consist of paresthesia around the mouth and abdominal pain followed by vomiting and diarrhea. Some patients have flushing, headache, urticaria and wheeze. The illness is usually self-limited and settles in a few hours.",
"   </p>",
"   <p>",
"    Ciguatera fish poisoning occurs in the southwestern Pacific (especially Kiribati, Tuvalu, French Polynesia, Vanuatu and Cook Islands), Queensland and the Gulf of Carpentaria although it should be remembered that fish are sometimes transported large distances to be served in restaurants and feasts [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The fish responsible are at the top of the food chain and include cod, sturgeon fish, parrotfish, red bass, Spanish mackerel and barracuda. The toxin comes from dinoflagellates and binds to sodium channels, causing depolarization with acute diarrhea and abdominal pain, lasting two to four days. Subsequent neurologic symptoms include myalgia, paradoxical \"burning\" of skin on contact with cold water, paresthesias, and a mood disorder lasting weeks to months. Previous anecdotal reports of successful treatment with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    have not been born out by a randomized control trial that demonstrated no advantage over intravenous saline [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9113/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many regions, especially in PNG, are remote with few roads and poor access to medical facilities. Travelers to the southwestern Pacific should also be aware of the monsoonal nature of the weather and plan their travel accordingly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=see_link\">",
"       \"Patient information: Vaccines for travel (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=see_link\">",
"       \"Patient information: General travel advice (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Australia, New Zealand, and Oceania are relatively safe destinations for tourists and business travelers. People planning to spend more than two weeks in the region should make themselves aware of the likely risks, especially when visiting remote areas.",
"     </li>",
"     <li>",
"      Unique infections include Ross River Virus, Australian (Queensland) tick typhus, Murray Valley (Australian encephalitis), and melioidosis. Risk for envenomations and bites varies by region.",
"     </li>",
"     <li>",
"      Insect repellent is essential. Apparel should include protection from the sun and appropriate footwear. Precautions should be observed with food and water, especially when camping or in remote communities.",
"     </li>",
"     <li>",
"      Antimalarial prophylaxis should be prescribed according to published guidelines. Specific vaccines are not necessary for temperate Australia and New Zealand. Routine vaccinations including tetanus and poliomyelitis status should be up to date.",
"     </li>",
"     <li>",
"      Hepatitis A and B virus and typhoid vaccination should be considered, especially when visitors are staying in village-type accommodation. Vaccination for Japanese B encephalitis is only recommended for travelers who are going to live in established endemic areas.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Australian Bureau of Statistics. Year Book Australia 2003, Tourism. Canberra, ACT, Australia.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/2\">",
"      Currie B. Medicine in tropical Australia. Med J Aust 1993; 158:609, 612.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. CDC Travel Information: Australia and the South Pacific. Division of Quarantine, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 2004. Available at: www.cdc.gov/travel/austspac.htm (Accessed on March 08, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/4\">",
"      Suh KN, Kozarsky PE, Keystone JS. Evaluation of fever in the returned traveler. Med Clin North Am 1999; 83:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/5\">",
"      Lo Re V 3rd, Gluckman SJ. Fever in the returned traveler. Am Fam Physician 2003; 68:1343.",
"     </a>",
"    </li>",
"    <li>",
"     Yung AP, Ruff T, Toreesi J, et al.. Manual of Travel Medicine, 2nd ed, IP Communications, Melbourne 2004.",
"    </li>",
"    <li>",
"     Jarman J. Shigella outbreak in Northland linked to contaminated shellfish. New Zealand Public Health Surveillance Report, March 2006; 4:5. Available at: www.surv.esr.cri.nz/PDF_surveillance/NZPHSR/2006/NZPHSR2006March.pdf (Accessed on June 26, 2006).",
"    </li>",
"    <li>",
"     Lopez L, Sexton K, Carter P. The epidemiology of menigococcal disease in New Zealand in 2010. Institute of Environmental Science and Rsearch Ltd (ESR); Ministry of Health, Wellington, New Zealand, 2011.",
"    </li>",
"    <li>",
"     Notifiable Disease Surveillance. New Zealand Public Health Surveillance Rep 2006; 4:3. Available at: www.surv.esr.cri.nz/PDF_surveillance/NZPHSR/2006/NZPHSRJune2006.pdf (Accessed on June 29, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/10\">",
"      Liu C, Broom AK, Kurucz N, Whelan PI. Communicable Diseases Network Australia: National Arbovirus and Malaria Advisory Committee annual report 2004-05. Commun Dis Intell Q Rep 2005; 29:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/11\">",
"      Hearnden, M, Skelly, C, Dowler, H, Weinstein, P. Improving the surveillance of mosquitoes with disease-vector potential in New Zealand. NZ Public Health Rep 1999; 6:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/12\">",
"      Sexton DJ, Dwyer B, Kemp R, Graves S. Spotted fever group rickettsial infections in Australia. Rev Infect Dis 1991; 13:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/13\">",
"      Graves SR. Broadsheet number 44: Rickettsial diseases: the Australian story so far. Pathology 1998; 30:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/14\">",
"      Dyer JR, Einsiedel L, Ferguson PE, et al. A new focus of Rickettsia honei spotted fever in South Australia. Med J Aust 2005; 182:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/15\">",
"      Currie, B, Lo, D, Marks, G, et al. Fatal Scub Typhus from Litchfield Park, Northern Territory. Commun Dis Intell 1996; 20:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/16\">",
"      Kelly, H, Lubich, J, O'Conner, L. Two cases of murine typhus in Albany, Western Australia. Commun Dis Intell 1995; 19:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/17\">",
"      Roberts S, Hill P, Croxson M, et al. The evidence for rickettsial disease arising in New Zealand. N Z Med J 2001; 114:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/18\">",
"      Thornley CN, Baker MG, Weinstein P, Maas EW. Changing epidemiology of human leptospirosis in New Zealand. Epidemiol Infect 2002; 128:29.",
"     </a>",
"    </li>",
"    <li>",
"     WHO/FAO/OIE collaborating centre for reference and research on Leptospirosis. Australia and Pacific Region. Centre for Public Health Sciences. Queensland Health Services. Available at: file://health.qld.gov.au/qhpss/leptospirosis.asp (Accessed on June 29, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/20\">",
"      Smythe L, Dohnt M, Symonds M, et al. Review of leptospirosis notifications in Queensland and Australia: January 1998-June 1999. Commun Dis Intell 2000; 24:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/21\">",
"      Garner MG, Longbottom HM, Cannon RM, Plant AJ. A review of Q fever in Australia 1991-1994. Aust N Z J Public Health 1997; 21:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/22\">",
"      Hilbink F, Penrose M, Kovacova E, Kazar J. Q fever is absent from New Zealand. Int J Epidemiol 1993; 22:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/23\">",
"      Robson JM, Harrison MW, Wood RN, et al. Brucellosis: re-emergence and changing epidemiology in Queensland. Med J Aust 1993; 159:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/24\">",
"      Bramley, D, Taylor, S, Godfrey, K, Mackereth, G. The public health response to a case of brucellosis in Auckland. NZ Public Health Rep 2002; 9:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/25\">",
"      Cheng AC, Currie BJ. Venomous snakebites worldwide with a focus on the Australia-Pacific region: current management and controversies. J Intensive Care Med 2004; 19:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/26\">",
"      Isbister GK, White J. Clinical consequences of spider bites: recent advances in our understanding. Toxicon 2004; 43:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/27\">",
"      Storer E, Sheridan AT, Warren L, Wayte J. Ticks in australia. Australas J Dermatol 2003; 44:83.",
"     </a>",
"    </li>",
"    <li>",
"     Sutherland S, Tibballs J. Australian Animal Toxins: The creatures, their toxins and care of the poisoned patient, 2nd Ed, Oxford University Press, South Melbourne 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/29\">",
"      The National Notifiable Diseases Surveillance System (NNDSS). Japanese encephalitis on the Australian mainland. Commun Dis Intell 1998; 22:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/30\">",
"      Hanna JN, Ritchie SA, Phillips DA, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996; 165:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/31\">",
"      Shield, J, Hanna, J, Phillips, D. Reappearance of the Japanese encephalitis in the Torres Strait, 1996. Commun Dis Intell 1996; 20:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/32\">",
"      Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/33\">",
"      Hughes AJ, Biggs BA. Parasitic worms of the central nervous system: an Australian perspective. Intern Med J 2002; 32:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/34\">",
"      McCormack JG, Allworth AM. Emerging viral infections in Australia. Med J Aust 2002; 177:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/35\">",
"      O'Reilly GM, Isbister GK, Lawrie PM, et al. Prospective study of jellyfish stings from tropical Australia, including the major box jellyfish Chironex fleckeri. Med J Aust 2001; 175:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/36\">",
"      Bath NE. Health and safety problems and lack of information among international visitors backpacking through North Queensland. J Travel Med 2000; 7:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/37\">",
"      McBride WJ. HIV/AIDS in Papua New Guinea: an unfolding disaster? Emerg Med Australas 2005; 17:304.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Cruise Ship Travel: Health Recommendations, 2004. Available at: www.cdc.gov/travel/other/cruiseship_recommend.htm (Accessed on July 15, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/39\">",
"      M&uuml;ller I, Bockarie M, Alpers M, Smith T. The epidemiology of malaria in Papua New Guinea. Trends Parasitol 2003; 19:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/40\">",
"      O'Brien J. Malaria and prophylaxis among expatriate aid workers in the Solomon Islands: 1987 to 1992. Trop Doct 1993; 23:26.",
"     </a>",
"    </li>",
"    <li>",
"     CDC Travel Health. Malaria: general information. Available at: www.cdc.gov/travel/malinfo.htm (Accessed on July 15, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/42\">",
"      Trevett AJ, Sanders RC. Arbovirus disease in Papua New Guinea. P N G Med J 1994; 37:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/43\">",
"      Kiedrzynski, T, Souares, Y, Stewart, T. Dengue in the Pacific: An updated story. Pacific Health Dialog 1998; 5:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/44\">",
"      New Zealand Public Health Surveillance Rep 2003; 1:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/45\">",
"      Klapsing P, MacLean JD, Glaze S, et al. Ross River virus disease reemergence, Fiji, 2003-2004. Emerg Infect Dis 2005; 11:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/46\">",
"      Lo Re V 3rd, Gluckman SJ. Eosinophilic meningitis. Am J Med 2003; 114:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/47\">",
"      Perrocheau A, Perolat P. Epidemiology of leptospirosis in New Caledonia (South Pacific): a one-year survey. Eur J Epidemiol 1997; 13:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/48\">",
"      O'Leary FM, Hunjan JS, Bradbury R, Thanakrishnan G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004; 180:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/49\">",
"      Laurenson IF, Trevett AJ, Lalloo DG, et al. Meningitis caused by Cryptococcus neoformans var. gattii and var. neoformans in Papua New Guinea. Trans R Soc Trop Med Hyg 1996; 90:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/50\">",
"      Currie B. Melioidosis in Papua New Guinea: is it less common than in tropical Australia? Trans R Soc Trop Med Hyg 1993; 87:417.",
"     </a>",
"    </li>",
"    <li>",
"     Rifkin J, Williamson J, Fenner P. Anthozoans, hydrozoans and scyphozoans. In: Venomous &amp; Poisonous Marine Animals, Williamson JA, Fenner PJ, Burnett JW, Rifkin JF (Eds), University of New South Wales Press, Sydney 1996. p.180.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/52\">",
"      Cheng AC, Winkel KD. Snakebite and antivenoms in the Asia-Pacific: wokabaut wantaim, raka hebou (\"walking together\"). Med J Aust 2001; 175:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/53\">",
"      Sobel J, Painter J. Illnesses caused by marine toxins. Clin Infect Dis 2005; 41:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/54\">",
"      Isbister GK, Kiernan MC. Neurotoxic marine poisoning. Lancet Neurol 2005; 4:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/55\">",
"      Lehane L, Olley J. Histamine fish poisoning revisited. Int J Food Microbiol 2000; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/56\">",
"      Goodman A, Williams TN, Maitland K. Ciguatera poisoning in Vanuatu. Am J Trop Med Hyg 2003; 68:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/57\">",
"      Ng S, Gregory J. An outbreak of ciguatera fish poisoning in Victoria. Commun Dis Intell 2000; 24:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9113/abstract/58\">",
"      Schnorf H, Taurarii M, Cundy T. Ciguatera fish poisoning: a double-blind randomized trial of mannitol therapy. Neurology 2002; 58:873.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3894 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-0B2EC3AACF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9113=[""].join("\n");
var outline_f8_57_9113=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TEMPERATE AUSTRALIA AND NEW ZEALAND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Arbovirus infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Rickettsial infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Leptospirosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Envenomations and bites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Snakes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Spiders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Ticks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Sea creatures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Sandflies and midges",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TROPICAL AND CENTRAL AUSTRALIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Dengue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other arboviral infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Rickettsial and brucella infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Melioidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Envenomations and bites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Snakes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Crocodiles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Sea creatures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      OCEANIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Malaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Arboviral infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Eosinophilic meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Envenomations, toxins and bites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Snakes and sea creatures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Fish poisoning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3894\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3894|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/37/8787\" title=\"figure 1\">",
"      Australia and New Zealand",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3894|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/10/8366\" title=\"table 1\">",
"      Travel sx Australia NZ Oceania",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/16/24839?source=related_link\">",
"      Approach to the patient with a suspected spider bite: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38760?source=related_link\">",
"      Arthropod-borne encephalitides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39577?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations, and diagnosis of melioidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/0/43016?source=related_link\">",
"      Jellyfish stings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/54/43879?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25622?source=related_link\">",
"      Nipah and Hendra viral encephalitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36953?source=related_link\">",
"      Pathogenesis of dengue virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=related_link\">",
"      Patient information: General travel advice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/44/21187?source=related_link\">",
"      Patient information: Vaccines for travel (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/3/13370?source=related_link\">",
"      Prevention of malaria infection in travelers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31431?source=related_link\">",
"      Principles of snake bite management worldwide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41095?source=related_link\">",
"      Ross River virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=related_link\">",
"      Scrub typhus: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27796?source=related_link\">",
"      The epidemiology and clinical manifestations of murine typhus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_57_9114="Clinical manifestations, diagnosis, and management of undifferentiated spondyloarthritis and related spondyloarthritides";
var content_f8_57_9114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations, diagnosis, and management of undifferentiated spondyloarthritis and related spondyloarthritides",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9114/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9114/contributors\">",
"     David T Yu, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9114/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9114/contributors\">",
"     Joachim Sieper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/57/9114/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/57/9114/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/57/9114/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terms spondyloarthritis, spondyloarthritides, spondyloarthropathy, and spondyloarthropathies are used to refer to a family of diseases that share several clinical features. The most distinguishing features are inflammation of axial joints (especially the sacroiliac joints), asymmetric oligoarthritis (especially of the lower extremities), dactylitis (sausage digits), and enthesitis (inflammation at sites of ligamentous or tendon attachment to bone). Additional features are genital and skin lesions, eye and bowel inflammation, an association with preceding or ongoing infectious disorders, and a strong association with the human leukocyte antigen (HLA) B27 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/1\">",
"     1",
"    </a>",
"    ]. The preferred term for this family of arthritis is \"spondyloarthritis\" (SpA), and we will use this designation throughout the following discussion.",
"   </p>",
"   <p>",
"    The SpA family consists of the following disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Undifferentiated spondyloarthritis (USpA)",
"     </li>",
"     <li>",
"      Ankylosing spondylitis (AS)",
"     </li>",
"     <li>",
"      Reactive arthritis (formerly called Reiter syndrome)",
"     </li>",
"     <li>",
"      SpA associated with psoriasis or psoriatic arthritis",
"     </li>",
"     <li>",
"      SpA associated with Crohn's disease and ulcerative colitis",
"     </li>",
"     <li>",
"      Juvenile onset spondyloarthritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Spondyloarthritis with predominantly axial involvement is also designated as \"axial spondyloarthritis\"; spondyloarthritis with predominantly peripheral involvement is also designated as &ldquo;peripheral spondyloarthritis&rdquo;.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, and classification of the SpA family of disorders in adults will be reviewed here with a major focus on USpA. The management of USpA is briefly addressed here. The clinical manifestations and diagnosis of ankylosing spondylitis, psoriatic arthritis, and of spondyloarthropathy in children are discussed separately, as is the treatment of ankylosing spondylitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"     \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link\">",
"     \"Spondyloarthropathy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The estimated prevalence of SpA in a Caucasian population is approximately 0.5 to 2 percent. There is considerable variation worldwide, depending upon ethnicity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ankylosing spondylitis and USpA are the most frequent types of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/3\">",
"     3",
"    </a>",
"    ]. Reactive arthritis is much less frequent. Historically, the term \"Reiter syndrome\" was often used indiscriminately to encompass reactive arthritis and classical Reiter syndrome, the triad of arthritis, conjunctivitis, and urethritis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/4\">",
"     4",
"    </a>",
"    ]. Reactive arthritis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of SpA include musculoskeletal findings, genital, skin and mucosal lesions, eye involvement, and inflammation of the bowel mucosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Musculoskeletal features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Musculoskeletal manifestations of SpA include inflammatory back pain, peripheral arthritis, enthesitis, and dactylitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Inflammatory back pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Back pain is the most common symptom at disease onset, being present in about 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/2\">",
"     2",
"    </a>",
"    ]. Although back pain in general is a common complaint in primary care, back pain due to SpA is comparatively uncommon, and can frequently be distinguished from other causes of axial pain. By convention, the back pain of SpA is termed \"inflammatory back pain\", while those of other causes are termed \"mechanical back pain\". Clinical features of inflammatory spinal disease include the following: onset before the age of 40 years, insidious onset, improvement with exercise, no improvement with rest, and pain at night. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Peripheral arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peripheral arthritis in SpA usually has an acute onset and predominantly involves the lower extremities, especially the knees and ankles [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"     5",
"    </a>",
"    ]. However, any joint can be involved. Arthritis is typically asymmetrical and often affects only one to three joints [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. Arthritis of the knees and ankles can be accompanied by considerable swelling. When compared with other rheumatic diseases, the sensitivity and specificity of asymmetric oligoarthritis for SpA are 41 and 87 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Enthesitis (enthesopathy)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The enthesis is the site of insertion of ligaments, tendons, joint capsule, or fascia to bone; it is composed of dense collagen, fibrocartilage, and adjacent bursae and synovial folds [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/7\">",
"     7",
"    </a>",
"    ]. Enthesitis (or enthesopathy), which refers to inflammation around the enthesis, is relatively specific for SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common observable clinical manifestation of enthesitis is swelling at the heels, at the insertion of the Achilles tendon (",
"    <a class=\"graphic graphic_figure graphicRef81198 \" href=\"UTD.htm?6/42/6820\">",
"     figure 1",
"    </a>",
"    ), or the insertion of the plantar fascia ligament into the calcaneus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"     5",
"    </a>",
"    ]. They are usually associated with severe pain and tenderness. During physical examination, the patient has difficulty walking on the heels when barefoot. Swelling at the side of the Achilles tendon can be appreciated when the patient is observed in the standing position from behind. On palpation, there is tenderness at the sites of insertion of the Achilles tendon",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the plantar fascia on the calcaneus. Other sites of enthesitis which are not swollen but can be painful",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tender include those at the iliac crests, greater trochanters, epicondyles at the elbows, tibial plateaus, costochondral junctions at the sternum, humeral tuberosities, manubrial-sternal joints, occiput, and spinous processes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Dactylitis (sausage digits)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A characteristic feature of SpA, including psoriatic arthritis, is dactylitis, also known sausage toe or sausage finger (",
"    <a class=\"graphic graphic_picture graphicRef61696 \" href=\"UTD.htm?16/31/16881\">",
"     picture 1",
"    </a>",
"    ). Unlike synovitis, in which swelling is confined to the joints, with dactylitis the entire digit is swollen. Joints do not show the discrete palpable fusiform swelling of synovitis, and there may be surprisingly little pain or tenderness. The diffuse swelling arises from flexor tendon, sheath, and marked adjacent soft tissue involvement. Dactylitis is not specific for SpA and may also be seen when the bones of the digits are involved with tuberculosis, syphilis, sarcoidosis, sickle cell disease, and tophaceous gout [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Inflammatory eye disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conjunctivitis may be a manifestation of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/10\">",
"     10",
"    </a>",
"    ]. The involvement is typically transient with symptoms subsiding within a few weeks. A more serious problem is anterior uveitis (iritis) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/11\">",
"     11",
"    </a>",
"    ]. The initial attack is usually acute and unilateral and may be the presenting problem. Patients complain of redness, pain, and photophobia. Although ocular inflammation usually responds to topical therapy, permanent impairment of vision is possible if treatment with local glucocorticoids and mydriatics is unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/10/10407?source=see_link\">",
"     \"Uveitis: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We recommend that all patients with symptomatic eye involvement be referred to an ophthalmologist, because an accurate diagnosis of uveitis requires slit lamp examination. Episodes of iritis usually last several months and do not necessarily parallel the course of arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=see_link\">",
"     \"Uveitis: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Inflammation of the bowel mucosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to two-thirds of patients with SpA have inflammatory lesions of the bowel mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/13\">",
"     13",
"    </a>",
"    ]. These are usually clinically silent. There are two types of lesions: acute, which resembles acute bacterial enterocolitis; and a chronic ileocolitis, which is often indistinguishable from Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a strong relationship between active peripheral arthritis and histological gut inflammation. Approximately 10 percent of patients with inflammatory bowel disease present with signs or symptoms of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25289?source=see_link\">",
"     \"Arthritis associated with gastrointestinal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6377?source=see_link\">",
"     \"Mechanisms for the induction of rheumatic symptoms by gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute phase reactants, including the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are increased in some patients. Increased CRP, although with a limited sensitivity of not more than 50 percent, is one of the features of SpA used in the Assessment in SpondyloArthritis International Society (ASAS) classification criteria for axial SpA, and should be obtained in all patients suspected of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Axial SpA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Testing for bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing for bacterial infection that may cause reactive arthritis is useful for diagnosis of reactive arthritis but not in other forms of SpA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Testing for HLA-B27",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most ethnic groups, more than 90 percent of patients with ankylosing spondylitis and 70 percent of patients with USpA are HLA-B27 positive. HLA-B27 testing is recommended for all patients suspected of SpA. However, a positive HLA-B27 by itself is not diagnostic of SpA, because a significant proportion of subjects in the general population are also positive. HLA-B27 is especially useful in supporting the diagnosis of axial SpA in the 30 percent of axial SpA patients who lack sacroiliitis on imaging. HLA-B27 is also useful in that a negative test makes the diagnosis of ankylosing spondylitis less likely [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. The diagnosis of SpA should be doubted if both HLA-B27 and imaging for sacroiliitis are negative. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H27\">",
"     'Axial SpA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Testing for HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of SpA in human immunodeficiency virus (HIV)-infected patients are similar to those seen in HIV-negative individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/19\">",
"     19",
"    </a>",
"    ]. In areas of the world where HIV infections are highly prevalent, SpA may be common regardless of the presence of HLA-B27. As an example, among 702 consecutive patients attending an arthritis clinic in Zambia, 395 were diagnosed as having SpA, although rarely as having classical ankylosing spondylitis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/20\">",
"     20",
"    </a>",
"    ]. HIV seroprevalence was 94 percent in reactive arthritis, a prevalence that was similar to the 98 percent rate in USpA patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/21\">",
"     21",
"    </a>",
"    ]. At a time when 30 percent of the adult urban population in Zambia was seropositive for HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/21\">",
"     21",
"    </a>",
"    ]; HLA-B27 was absent in the 30 patients with USpA who were tested for this major histocompatibility antigen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several imaging findings that are fairly specific for SpA and can aid in the diagnosis. Plain radiographs are the imaging procedure of choice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]. MRI should only be used when plain radiographs are normal but there is still a high index of suspicion for SpA, especially if the designation of SpA in that particular patient will significantly affect choice of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs of the spine, sacroiliac joints, and involved peripheral joints and entheses may be helpful in longstanding SpA, but exhibit informative changes less often in early or undifferentiated SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]. Sacroiliac joint changes, but not changes at the other sites, are used in these classification criteria for SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]. A plain AP radiograph of the pelvis for assessment of sacroiliitis is recommended in all patients suspected of SpA because in the case of findings consistent with definite sacroiliitis a diagnosis of AS can normally be made. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H26\">",
"     'ASAS Classification criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Axial radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only plain radiograph findings that are specific for SpA are those of sacroiliitis. In less than 5 percent of AS patients, AS-typical syndesmophytes might be found in the spine in the absence of radiographic sacroiliitis. However, it may take several years from the onset of disease before radiographic sacroiliitis becomes apparent. For each plain radiograph, the right and left sacroiliac joint should be evaluated separately, and assigned a grade based upon the presence of the characteristic radiographic findings as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grade 0: normal",
"     </li>",
"     <li>",
"      Grade 1: suspicious changes",
"     </li>",
"     <li>",
"      Grade 2: minimal abnormality &ndash; small localized areas with erosions or sclerosis, without alteration in the joint width",
"     </li>",
"     <li>",
"      Grade 3: unequivocal abnormality &ndash; moderate or advanced sacroiliitis with one or more of: erosions, evidence of sclerosis, widening, narrowing, or partial ankylosis",
"     </li>",
"     <li>",
"      Grade 4: severe abnormality &ndash; total ankylosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examples of the various grades are reviewed separately and also available in the ASAS slide library of x-ray images at",
"    <a class=\"external\" href=\"file://www.asas-group.org/\">",
"     file://www.asas-group.org",
"    </a>",
"    (accessed February 8, 2011). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A patient is regarded as positive for evidence of radiographic sacroiliitis if the radiographic study is rated at grade 2 or higher bilaterally, or grade 3 or higher unilaterally [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At least 50 percent of patients with ankylosing spondylitis also develop syndesmophytes of the spine in the course of their disease. These syndesmophytes have a typical appearance and are easily differentiated from degenerative spinal osteophytes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Peripheral joints",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs of peripheral joints are usually unremarkable and do not show the same type of erosions seen in rheumatoid arthritis. Fluffy erosions can be seen in areas of enthesitis such as the heels, while supportive of they are not specifically diagnostic of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;We obtain magnetic resonance imaging (MRI) in patients suspected of SpA but without plain radiographic evidence of sacroiliitis to assist in the diagnosis. MRI of the sacroiliac joints is not necessary in evaluating patients for possible SpA if there is already evidence of sacroiliitis on plain radiographs or if the patient has already fulfilled the ASAS criteria by other parameters, unless additional information regarding the presence or absence of active inflammation (subchondral bone marrow edema) is desired [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Axial SpA'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H32\">",
"     'Peripheral SpA'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The interpretation of MRI changes has to be made in the context of all clinical, laboratory, and imaging parameters typical for SpA available. We thus prefer that a rheumatologist involved in the care of a given patient participates in the assessment and interpretation of the imaging findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2569607\">",
"    <span class=\"h3\">",
"     MRI evaluation of SI joint",
"    </span>",
"    &nbsp;&mdash;&nbsp;A consensus opinion on how to diagnose sacroiliitis based upon MRI has been issued by the Assessment of SpondyloArthritis international Society",
"    <span class=\"nowrap\">",
"     (ASAS)/Outcome",
"    </span>",
"    Measures in Rheumatology (OMERACT) MRI working group [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following findings are considered critical:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Active inflammatory lesions of the sacroiliac (SI) joints. These lesions appear as bone marrow edema (BME) (on short t inversion recovery [STIR], or T2 with fat absorption images) and are clearly present in typical locations (subchondral or periarticular bone marrow). These lesions should not be present in the T1 weighted images.",
"     </li>",
"     <li>",
"      If there is only one BME lesion for each MRI slice, the lesion should be present on at least two consecutive slices. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"       \"Clinical manifestations of ankylosing spondylitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following findings, by themselves, are not sufficient but support the diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of other active inflammatory lesions such as synovitis, enthesitis or capsulitis",
"     </li>",
"     <li>",
"      Structural lesions such as fat deposition, sclerosis, erosions, or bony ankylosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity and specificity of BME are illustrated by a study that compared 54 patients with a short duration of inflammatory back pain and non-diagnostic plain radiographs to 11 patients with mechanical low back pain and to 11 healthy control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/26\">",
"     26",
"    </a>",
"    ]. Bone marrow edema was observed in 85 percent of patients with inflammatory back pain and in 40 percent of the control group. However, moderate or severe lesions were observed only in patients with inflammatory back pain. The above studies are based on the",
"    <span class=\"nowrap\">",
"     ASAS/OMERACT",
"    </span>",
"    consensus criteria.",
"   </p>",
"   <p>",
"    Improvements for the definition of a positive MRI have been proposed by the Canada-Denmark MRI Working Group (MORPHO) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/27\">",
"     27",
"    </a>",
"    ]. In addition to bone marrow edema, the MORPHO criteria also included joint erosion and ankylosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/28\">",
"     28",
"    </a>",
"    ]. This would potentially lead to an improved sensitivity of 81 percent and a similar specificity of 88 percent. Thus, some modifications of the definitions might be possible in the near future [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of a positive HLA-B27 and severe bone marrow edema of the SI joints on MRI may be predictive for progression to ankylosing spondylitis, but further confirmation of this observation is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI might have a limited sensitivity for the detection of subchondral bone marrow edema. One study has suggested that the sensitivity of MRI for detecting sacroiliitis is only modest [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/31\">",
"     31",
"    </a>",
"    ]. In this study, the presence of sacroiliitis demonstrated by CT-guided needle biopsy of the sacroiliac joint was used to determine whether or not sacroiliitis was present in 109 patients suspected of axial spondyloarthritis in whom the plain radiographs or CT of the sacroiliac joints showed grade 1 or grade 0 (normal) findings. The sensitivity and specificity of MRI in diagnosing sacroiliitis determined histologically was 38 and 100 percent, respectively. However, MRI-negative and biopsy-positive patients developed radiographic sacroiliitis less frequently than MRI-positive and biopsy-positive patients over a 5- to 10-year follow-up period, indicating that development of radiographic sacroiliitis correlates with severity of the inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10513757\">",
"    <span class=\"h2\">",
"     CT scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computerized tomography (CT) is more sensitive than plain radiography for the detection of structural changes in the sacroiliac joints [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/32\">",
"     32",
"    </a>",
"    ]. However, CT scanning has several disadvantages compared with MRI. CT and MR imaging are comparable to each other for the detection of bony changes such as erosions and sclerosis, but only MR allows detection and analysis of inflammatory changes in subchondral bone and entheses (STIR sequence) and the detection of fatty change (T1-sequence) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/25,33\">",
"     25,33",
"    </a>",
"    ]. Moreover, radiation exposure from CT studies is a clear disadvantage compared with MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone scintigraphy reveals high uptake in areas of inflammation. However, it is too nonspecific to be useful for diagnosis of SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies using B-mode ultrasound with power Doppler capability (PDUS) have revealed abnormal vascularization at the entheses in patients with SpA. However, the technique is operator and machine-type dependent. Until standardization and perhaps useful analytic software is available, ultrasound is useful only in centers or by clinicians with extensive experience [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4392?source=see_link&amp;anchor=H13#H13\">",
"     \"Musculoskeletal ultrasonography: Clinical applications\", section on 'Entheses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DEFINITIONS OF SPONDYLOARTHRITIS SUBTYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discussions of the definition of adult USpA are presented below. The definitions of ankylosing spondylitis (AS) and psoriatic arthritis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"     \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Childhood disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood SpA is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link\">",
"     \"Spondyloarthropathy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Undifferentiated spondyloarthritis (USpA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted earlier, the term \"undifferentiated spondyloarthritis\" (USpA) is used to refer to SpA patients who do not meet established classification criteria for ankylosing spondylitis, reactive arthritis, psoriatic arthritis, or SpA related to inflammatory bowel disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/16\">",
"     16",
"    </a>",
"    ]. These patients can be split into predominant axial USpA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    predominant peripheral USpA, based upon whether they present predominantly with back pain or with peripheral",
"    <span class=\"nowrap\">",
"     arthritis/enthesitis.",
"    </span>",
"    (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Most patients with axial USpA (also termed non-radiographic axial SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/13,18\">",
"     13,18",
"    </a>",
"    ]) are young men with low back pain, some of whom also have peripheral arthritis. A minority present with predominantly peripheral involvement, such as arthritis, enthesitis or dactylitis, and a subset of these patients do not have any back discomfort. The majority of patients with USpA are HLA-B27-positive [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major difference between axial USpA and ankylosing spondylitis is that plain film radiographic evidence of sacroiliitis is either absent or mild in USpA. Both ankylosing spondylitis and USpA, whose major clinical feature is back pain, may be referred to as \"axial spondyloarthritis\". In addition, the back pain characteristic of these disorders is termed \"inflammatory back pain\" to distinguish from other causes of back pain termed \"mechanical back pain\".",
"   </p>",
"   <p>",
"    A major question is how to distinguish patients with axial SpA from those with mechanical back pain, and peripheral SpA from those with other inflammatory arthritis. This is especially demanding for those patients with early disease in whom plain radiographs of sacroiliac joints are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/35\">",
"     35",
"    </a>",
"    ]. This question was addressed by a large multicenter study carried out by the Assessment in SpondyloArthritis International Society (ASAS) working group. Their recommendations will be presented in subsequent sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to recognize that there are no \"diagnostic criteria\" for SpA per se. Based upon our clinical experience, we generally make the diagnosis of SpA in a patient who fulfills one of the three major classification criteria sets discussed below. However, a clinical diagnosis of USpA should be considered tentative; a substantial proportion of such patients will either enter remission or evolve into a more specifically classifiable subset. Patients who present initially with only peripheral involvement may subsequently also develop axial involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'ASAS Classification criteria'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H33\">",
"     'ESSG criteria'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H34\">",
"     'Amor criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The classification criteria were developed for use in epidemiological and clinical research and do not carry the specificity to be used as the only diagnostic tools in the clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/37\">",
"     37",
"    </a>",
"    ]. The &ldquo;gold standard&rdquo; for identifying whether a particular patient had SpA or not that was used for the development of the classification criteria was the opinion of an expert, whose degree of confidence in diagnosing each patient was expressed on a scale of 0-10.",
"   </p>",
"   <p>",
"    It would be rather unlikely for a patient to have SpA if that patient does not satisfy any of the three sets of criteria. More simply, it would be unlikely for a patient to have AS or axial USpA if the HLA-B27 test is negative and the imaging of the sacroiliac joints does not show sacroiliitis. For the diagnosis of axial SpA, a diagnostic algorithm has been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/18,23\">",
"     18,23",
"    </a>",
"    ]. The ability to make an early diagnosis of SpA in patients with a high level of disease activity has become more important since effective therapies are available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=see_link\">",
"     \"Assessment and treatment of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     ASAS CLASSIFICATION CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two sets of classification criteria for SpA that have been issued by the Assessment of SpondyloArthritis international Society (ASAS), one for those presenting with axial involvement (see",
"    <a class=\"local\" href=\"#H27\">",
"     'Axial SpA'",
"    </a>",
"    below), and the other for those presenting with peripheral involvement (see",
"    <a class=\"local\" href=\"#H32\">",
"     'Peripheral SpA'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"     22",
"    </a>",
"    ]. These classification criteria were generated from a cross-sectional study of patients newly referred for possible SpA and control arthritis patients. In the ASAS study population, in patients (largely) under age 45 and presenting with either undiagnosed back pain or peripheral arthritis (or enthesitis or dactylitis) at the time seen, the combined criteria had a sensitivity of 80 percent and specificity of 83 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. These criteria compared favorably with other previously established criteria sets. (See",
"    <a class=\"local\" href=\"#H10431996\">",
"     'Other SpA classification criteria'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H33\">",
"     'ESSG criteria'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H34\">",
"     'Amor criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Axial SpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification criteria for axial SpA, including criteria for those without plain radiographic changes of sacroiliitis, were based upon a large multicenter study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/15\">",
"     15",
"    </a>",
"    ]. In patients with a history of back pain of unknown origin, which was at least 3 months duration and began before age 45, the classification criteria for axial SpA exhibited sensitivity of 83 percent and specificity of 84 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/15\">",
"     15",
"    </a>",
"    ]. There are three steps in the algorithm:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The entry step is that the patient must have had back pain of any type for at least three months and an age of onset of less than 45 years.",
"     </li>",
"     <li>",
"      The second step consists of two arms that are evaluated separately based upon the presence of either sacroiliitis on imaging or HLA-B27:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      HLA-B27 positive patients &mdash; In patients who test positive for HLA-B27, at least two additional features of SpA from the list below are required for classifying a patient as having axial SpA. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'SpA features'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Sacroiliitis on imaging &mdash; In patients with sacroiliitis diagnosed based upon plain radiographs or MRI, at least one other feature of SpA from the list below should be present (see",
"      <a class=\"local\" href=\"#H28\">",
"       'SpA features'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H19\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     SpA features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are SpA features that contribute to the classification criteria for axial SpA (see above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory back pain &mdash; For classification purposes, inflammatory back pain is defined as having at least four of the five following parameters [",
"      <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/38\">",
"       38",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Age of onset &lt;40 years",
"     </li>",
"     <li>",
"      Insidious onset",
"     </li>",
"     <li>",
"      Improvement with exercise",
"     </li>",
"     <li>",
"      No improvement with rest",
"     </li>",
"     <li>",
"      Pain at night (with improvement upon arising)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other SpA features (each of equal weight) &mdash; Other SpA features include the presence of one or more nonspinal features noted below. The occurrence can be either in the past or at the time of evaluation for the following items listed: arthritis, heel enthesitis, uveitis, dactylitis, psoriasis, inflammatory bowel disease. The features are:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Arthritis &ndash; as diagnosed by a physician",
"     </li>",
"     <li>",
"      Heel enthesitis &ndash; spontaneous pain or tenderness at site of insertion of Achilles tendon or plantar fascii at the calcaneus",
"     </li>",
"     <li>",
"      Uveitis &ndash; confirmed by an ophthalmologist",
"     </li>",
"     <li>",
"      Dactylitis &ndash; diagnosed by a physician",
"     </li>",
"     <li>",
"      Psoriasis &ndash; diagnosed by a physician",
"     </li>",
"     <li>",
"      Inflammatory bowel disease &ndash; Crohn's disease or ulcerative colitis diagnosed by a physician",
"     </li>",
"     <li>",
"      Good response to NSAIDs &ndash; within 24 to 48 hours",
"     </li>",
"     <li>",
"      Family history of SpA &ndash; presence in first or second degree relatives of any of the following: ankylosing spondylitis, psoriasis, acute uveitis, reactive arthritis, inflammatory bowel disease",
"     </li>",
"     <li>",
"      Elevated CRP &ndash; after exclusion of other causes for elevated CRP",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Peripheral SpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification criteria for peripheral SpA were based upon analyses of data from a cross-sectional international multicenter study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. In patients with undiagnosed peripheral arthritis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    enthesitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dactylitis, the ASAS classification criteria for peripheral SpA had a sensitivity of 78 percent and a specificity of 83 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. In the study, 85 percent of the patients were under age 45. &nbsp;For classification as having peripheral SpA, the patient should NOT have concurrent inflammatory back pain. In contrast, patients classified as having axial SpA should have back pain at the time they are being seen. There are two steps in the algorithm for classifying peripheral SpA:",
"   </p>",
"   <p>",
"    The entry step is that the patient should have, at the time of being seen, at least one of the following three findings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Arthritis",
"     </li>",
"     <li>",
"      Enthesitis (spontaneous pain or tenderness at site of insertion of Achilles tendon or plantar fascii at the calcaneus)",
"     </li>",
"     <li>",
"      Dactylitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the patient satisfies the entry criteria, the patient should show at least one of the features of SpA in Group A SpA features (below) or at least two of the features of SpA in group B.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Group A SpA features:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Uveitis",
"     </li>",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Crohn&rsquo;s/ulcerative",
"      </span>",
"      colitis",
"     </li>",
"     <li>",
"      Preceding infection",
"     </li>",
"     <li>",
"      HLA-B27",
"     </li>",
"     <li>",
"      Sacroiliitis on imaging",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Group B SpA features:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Arthritis",
"     </li>",
"     <li>",
"      Enthesitis",
"     </li>",
"     <li>",
"      Dactylitis",
"     </li>",
"     <li>",
"      Inflammatory back pain in the past",
"     </li>",
"     <li>",
"      Family history of SpA",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19711177\">",
"    <span class=\"h2\">",
"     Undifferentiated peripheral SpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient can be classified as having peripheral USpA if the patient presents predominantly with arthritis, enthesitis or dactylitis, the classification criteria for peripheral SpA are fulfilled, and there is no current diagnosis of psoriatic arthritis, arthritis associated with inflammatory bowel disease, or reactive arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18317328\">",
"    <span class=\"h2\">",
"     Screening and referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of the following findings should prompt HLA-B27 testing and referral to a rheumatologist for further evaluation if the diagnosis is uncertain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory back pain OR one of the following clinical features:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Oligoarthritis",
"     </li>",
"     <li>",
"      Sausage digit(s)",
"     </li>",
"     <li>",
"      Swelling and pain at the heel",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10431996\">",
"    <span class=\"h1\">",
"     OTHER SPA CLASSIFICATION CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the European Spondyloarthritides Study Group (ESSG) and Amor criteria used more extensively in the past will probably not be used for future research, they are still helpful for clinical guidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     ESSG criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The European Spondyloarthritides Study Group (ESSG) criteria set has the appeal of simplicity, and is the result of a study of 140 SpA patients and 1829 controls seen in seven countries by rheumatologists who specialize in SpA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"     5",
"    </a>",
"    ]. Although the patients are European, the criteria have been validated in other populations and are likely to be applicable worldwide. Among the ESSG cohort of patients with all forms of spondyloarthritis, the sensitivity and specificity are 86 and 87 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"     5",
"    </a>",
"    ]. In the ASAS cohort of patients largely under age 45 and with either undiagnosed back pain or peripheral arthritis (or enthesitis or dactylitis), the ESSG criteria had a sensitivity of 67 percent and specificity of 72 percent for SpA (including axial and peripheral SpA) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'ASAS Classification criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A patient is classified as having spondyloarthritis if he or she has at least one of two entry criteria plus one of the other criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ESSG entry criteria &mdash; To satisfy entry criteria, a patient must either have synovitis that is asymmetric or predominantly in the lower limbs or have inflammatory back pain. These are defined as follows:",
"      <br/>",
"      <br/>",
"      Asymmetrical synovitis &mdash; Asymmetrical synovitis, predominantly of the lower limbs is manifested by soft tissue swelling, warmth over a joint, joint effusion, and reductions in both active and passive range of motion. As with inflammatory spinal pain, the symptoms are worse after a period of rest.",
"      <br/>",
"      <br/>",
"      Inflammatory back pain &mdash; Back pain is considered inflammatory if four of the following five criteria are found:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Onset of back discomfort before the age of 45 years",
"     </li>",
"     <li>",
"      Insidious onset",
"     </li>",
"     <li>",
"      Persistence for at least three months",
"     </li>",
"     <li>",
"      Associated with morning stiffness",
"     </li>",
"     <li>",
"      Improvement with exercise (A useful clue is the complaint of waking up at night and walking around to avoid back pain.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Additional ESSG parameters &mdash; If a patient has one or both of the entry criteria listed above, he or she should then be evaluated for the presence of one or more of the following features:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Positive family history of first or second-degree relative with ankylosing spondylitis, psoriasis, acute uveitis, reactive arthritis, or inflammatory bowel disease",
"     </li>",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      Inflammatory bowel disease",
"     </li>",
"     <li>",
"      Urethritis, cervicitis, or acute diarrhea within one month before arthritis",
"     </li>",
"     <li>",
"      Buttock pain alternating between buttocks",
"     </li>",
"     <li>",
"      Enthesopathy",
"     </li>",
"     <li>",
"      Plain film radiographic evidence of sacroiliitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once a patient has been determined to fulfill the criteria for SpA, they should be further evaluated to determine which SpA subtype is most likely to be present. SpA associated with psoriasis, ulcerative colitis, or Crohn's disease is diagnosed by the corresponding associated diseases. In some patients, however, the development of arthritis may precede the development of the associated diseases so that the proper classification may only be apparent with the passage of time.",
"   </p>",
"   <p>",
"    There can also be some confusion in those with SpA and inflammation of the bowel mucosa not extensive enough to be classified as ulcerative colitis or Crohn's disease. In some of these patients, bowel symptoms and bleeding can be considerable. Some of these patients eventually develop classic Crohn's disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6377?source=see_link\">",
"     \"Mechanisms for the induction of rheumatic symptoms by gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Amor criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to the ESSG criteria are those proposed by Amor and colleagues [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/39\">",
"     39",
"    </a>",
"    ]. If present, each criterion is assigned a weight (1 or 2 points) and the resulting points are summed. A patient is considered as having a spondyloarthritis if the sum of the weighted criteria scores is at least six. The Amor criteria include clinical and historical items, radiographic findings, genetic factors, and response to NSAIDs. When the Amor criteria was applied to the cohort in the ASAS study population of patients, who were largely under age 45 and with either undiagnosed back pain or peripheral arthritis (or enthesitis or dactylitis), the combined criteria had a sensitivity of 56 percent and specificity of 87 percent for SpA (including axial and peripheral SpA) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'ASAS Classification criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The criteria and weights are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical symptoms or past history of:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lumbar or dorsal pain during the night, or morning stiffness of lumbar or dorsal pain = 1",
"     </li>",
"     <li>",
"      Asymmetrical oligoarthritis = 2",
"     </li>",
"     <li>",
"      Buttock pain (buttock pain = 1, if affecting alternately the right and the left buttock = 2).",
"     </li>",
"     <li>",
"      Sausage-like toe or digit = 2",
"     </li>",
"     <li>",
"      Heel pain = 2",
"     </li>",
"     <li>",
"      Iritis = 2",
"     </li>",
"     <li>",
"      Nongonococcal urethritis or cervicitis accompanying, or within one month before, the onset of arthritis = 1",
"     </li>",
"     <li>",
"      Acute diarrhea accompanying, or within one month before, the onset of arthritis = 1",
"     </li>",
"     <li>",
"      Presence of history of psoriasis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      balanitis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      of inflammatory bowel disease (ulcerative colitis, Crohn's disease) = 2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiologic finding &ndash; Sacroiliitis (grade &ge;2 if bilateral; grade &ge;3 if unilateral) = 3",
"     </li>",
"     <li>",
"      Genetic background &ndash; Presence of HLA-B27",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      family history of ankylosing spondylitis; the triad of uveitis, urethritis, and arthritis; psoriasis; uveitis alone; or chronic enterocolopathies = 2",
"     </li>",
"     <li>",
"      Response to treatment &ndash; Clear-cut improvement of rheumatic complaints with nonsteroidal anti-inflammatory drugs (NSAIDs) in less than 48 hours or relapse of the pain in less than 48 hours if NSAIDs discontinued = 2",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major arthritic conditions that must be distinguished from SpA are rheumatoid arthritis, gonococcal arthritis, and psoriatic arthritis. The most commonly observed patterns in these four diseases are compared in the table (",
"    <a class=\"graphic graphic_table graphicRef72238 \" href=\"UTD.htm?23/7/23676\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some important distinguishing features are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symmetrical polyarthritis of the small joints is characteristic of rheumatoid arthritis but not SpA.",
"     </li>",
"     <li>",
"      The presence of sausage digits (dactylitis) is suggestive of SpA or psoriatic arthritis but may also be present in tophaceous gout and sarcoidosis. The characteristic skin rash and nail lesions usually establish the diagnosis of psoriatic arthritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"       \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As mentioned, patients with SpA comprise a small minority of all patients with back pain. The other causes of back pain are too numerous to list here. Diagnostic approaches to adults and children with back pain are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link\">",
"     \"Evaluation of the child with back pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     ASSESSMENT OF DISEASE ACTIVITY IN AXIAL USpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar scores for assessing disease activity to those used in ankylosing spondylitis have been applied in clinical trials with axial USpA patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The following have been used:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bath Ankylosing Spondylitis index (BASDAI) used for ankylosing spondylitis",
"     </li>",
"     <li>",
"      Number of swollen joints",
"     </li>",
"     <li>",
"      Number of tender or swollen entheses",
"     </li>",
"     <li>",
"      Acute phase reactants",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY OF USpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, a patient diagnosed initially as USpA may evolve into a more specific type of SpA, especially ankylosing spondylitis, may develop into other forms of arthritis, continue unchanged, or go into remission. In a 10-year follow-up of 111 patients initially diagnosed with USpA, only 17 percent still had the same diagnosis 10 years later, with a significant number entering remission (23 percent) or evolving into ankylosing spondylitis (24 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The proportion of patients with early axial SpA but without radiographic sacroiliitis, who will eventually develop radiographic sacroiliitis, is uncertain. In a longitudinal study of 95 patients with axial SpA who did not have radiographic sacroiliitis at the time of recruitment, radiographic sacroiliitis developed after two years in 11.6 percent of the patients, , fulfilling the classification criteria for AS [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18712069\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF USpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are very few studies which focus specifically on the management of USpA itself. The approach to the management of axial SpA follows the same strategy as that which is used for AS, because axial SpA is regarded as a form of early AS. This treatment approach is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=see_link\">",
"     \"Assessment and treatment of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with USpA with only peripheral involvement,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    is the preferred disease-modifying antirheumatic drug, as discussed in detail elsewhere for the management of patients with AS who have peripheral involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?8/57/9114/abstract/16,44\">",
"     16,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=see_link\">",
"     \"Assessment and treatment of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/0/30721?source=see_link\">",
"       \"Patient information: Reactive arthritis (formerly Reiter syndrome) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/38/19045?source=see_link\">",
"       \"Patient information: Ankylosing spondylitis and spondyloarthritis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spondyloarthritis (SpA), formerly termed spondyloarthropathy, refers to a group of diseases that share certain clinical features, including: axial inflammation (spinal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sacroiliac), enthesitis, dactylitis, oligoarthritis, inflammatory eye disease, inflammatory bowel disease, an association with prior or ongoing infection, mucocutaneous lesions typically affecting the oral or genital regions and, importantly, the human leukocyte antigen HLA-B27.",
"     </li>",
"     <li>",
"      Subsets of SpA include: ankylosing spondylitis, undifferentiated spondyloarthritis (USpA), reactive arthritis, psoriatic arthritis, inflammatory bowel related disease, and SpA in children. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Definitions of spondyloarthritis subtypes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no diagnostic criteria for SpA. Guidance is provided by classification criteria. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no single laboratory test that by itself definitively establishes the diagnosis of USpA. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If there is a history of a preceding diarrheal illness or there is a significant risk of sexually transmitted disease or of HIV infection, we suggest appropriate testing of stool, genitourinary, and other potentially involved mucosal sites for bacterial infection and blood testing for HIV. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest testing for HLA-B27 in patients with back pain for more than three months and onset before age 45 years. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Testing for HLA-B27'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs of the sacroiliac joints reveal sclerosis, joint space widening, and erosion. MRI of the sacroiliac joint is indicated in patients with clinically suspected axial SpA who have negative or indeterminate plain radiographic findings at the sacroiliac joints. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Imaging'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"       \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of AS or USpA is unlikely if a patient is negative for both HLA-B27 and sacroiliitis by imaging.",
"     </li>",
"     <li>",
"      The differential diagnosis of USpA includes rheumatoid arthritis, gonococcal arthritis, psoriatic arthritis (sine psoriasis). (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sets of classification criteria for axial and peripheral SpA have been developed for epidemiological and clinical research purposes. They provide a certain degree of specificity in clinical diagnosis, but should not be relied upon as the only parameters. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'ASAS Classification criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because uveitis can only be diagnosed by slit lamp examination, we recommend referral to an eye specialist if uveitis is suspected. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Inflammatory eye disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/1\">",
"      Healy PJ, Helliwell PS. Classification of the spondyloarthropathies. Curr Opin Rheumatol 2005; 17:395.",
"     </a>",
"    </li>",
"    <li>",
"     Zeidler H, Brandt J, Schnarr S. Undifferentiated spondyloarthritis. In: Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology, 3rd, Weisman MH, Reveille JD, van der Heijde D (Eds), Elsevier, Philadelpha 2006. p.75.",
"    </li>",
"    <li>",
"     Fan PT, Yu DT. Reiter's syndrome. In: Textbook of Rheumatology, 4th, Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (Eds), Saunders, Philadelphia 1993. p.961.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/4\">",
"      Panush RS, Paraschiv D, Dorff RE. The tainted legacy of Hans Reiter. Semin Arthritis Rheum 2003; 32:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/5\">",
"      Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/6\">",
"      Rudwaleit M, van der Heijde D, Landew&eacute; R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/7\">",
"      D'Agostino MA, Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol 2006; 20:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/8\">",
"      Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/9\">",
"      Healy PJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr Rheumatol Rep 2006; 8:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/10\">",
"      Al-Amayreh IA, Zaidat BO. Ankylosing spondylitis in Northern Jordan. Saudi Med J 2000; 21:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/11\">",
"      Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989; 16:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/12\">",
"      Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/13\">",
"      De Keyser F, Baeten D, Van den Bosch F, et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002; 4:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/14\">",
"      Van Praet L, Jacques P, Van den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol 2012; 8:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/15\">",
"      Rudwaleit M, van der Heijde D, Landew&eacute; R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/16\">",
"      Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 2005; 44:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/17\">",
"      Brown MA. Human leucocyte antigen-B27 and ankylosing spondylitis. Intern Med J 2007; 37:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/18\">",
"      Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005; 52:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/19\">",
"      Winchester R, Bernstein DH, Fischer HD, et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987; 106:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/20\">",
"      Njobvu P, McGill P. Human immunodeficiency virus related reactive arthritis in Zambia. J Rheumatol 2005; 32:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/21\">",
"      Njobvu P, McGill P, Kerr H, et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998; 25:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/22\">",
"      Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 Suppl 2:ii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/23\">",
"      Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004; 63:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/24\">",
"      Resnick D, Feingold ML, Curd J, et al. Calcaneal abnormalities in articular disorders. Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and Reiter syndrome. Radiology 1977; 125:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/25\">",
"      Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/26\">",
"      Marzo-Ortega H, McGonagle D, O'Connor P, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009; 68:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/27\">",
"      Weber U, Lambert RG, &Oslash;stergaard M, et al. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 2010; 62:3048.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.arthritisdoctor.ca/mri.php (Accessed on July 26, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/29\">",
"      Aydin SZ, Maksymowych WP, Bennett AN, et al. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 2012; 71:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/30\">",
"      Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58:3413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/31\">",
"      Gong Y, Zheng N, Chen SB, et al. Ten years' experience with needle biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum 2012; 64:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/32\">",
"      Devauchelle-Pensec V, D'Agostino MA, Marion J, et al. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum 2012; 64:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/33\">",
"      Puhakka KB, Jurik AG, Egund N, et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol 2003; 44:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/34\">",
"      Song IH, Carrasco-Fern&aacute;ndez J, Rudwaleit M, Sieper J. The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research. Ann Rheum Dis 2008; 67:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/35\">",
"      Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/36\">",
"      Burgos-Vargas R, Casasola-Vargas JC. From retrospective analysis of patients with undifferentiated spondyloarthritis (SpA) to analysis of prospective cohorts and detection of axial and peripheral SpA. J Rheumatol 2010; 37:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/37\">",
"      Collantes E, Veroz R, Escudero A, et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2000; 67:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/38\">",
"      Sieper J, van der Heijde D, Landew&eacute; R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009; 68:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/39\">",
"      Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 1990; 57:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/40\">",
"      Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009; 60:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/41\">",
"      Braun J, Zochling J, Baraliakos X, et al. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 2006; 65:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/42\">",
"      Sampaio-Barros PD, Bortoluzzo AB, Conde RA, et al. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010; 37:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/43\">",
"      Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012; 64:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/57/9114/abstract/44\">",
"      Cruzat V, Cuchacovich R, Espinoza LR. Undifferentiated spondyloarthritis: recent clinical and therapeutic advances. Curr Rheumatol Rep 2010; 12:311.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7795 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-906C751B57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9114=[""].join("\n");
var outline_f8_57_9114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Musculoskeletal features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Inflammatory back pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Peripheral arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Enthesitis (enthesopathy)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Dactylitis (sausage digits)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Inflammatory eye disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Inflammation of the bowel mucosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Testing for bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Testing for HLA-B27",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Testing for HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Axial radiographs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Peripheral joints",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2569607\">",
"      - MRI evaluation of SI joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10513757\">",
"      CT scanning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DEFINITIONS OF SPONDYLOARTHRITIS SUBTYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Childhood disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Undifferentiated spondyloarthritis (USpA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      ASAS CLASSIFICATION CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Axial SpA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - SpA features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Peripheral SpA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19711177\">",
"      Undifferentiated peripheral SpA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18317328\">",
"      Screening and referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10431996\">",
"      OTHER SPA CLASSIFICATION CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      ESSG criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Amor criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      ASSESSMENT OF DISEASE ACTIVITY IN AXIAL USpA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      NATURAL HISTORY OF USpA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18712069\">",
"      MANAGEMENT OF USpA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7795\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7795|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/42/6820\" title=\"figure 1\">",
"      Achilles calcaneus enthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7795|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/31/16881\" title=\"picture 1\">",
"      Sausage toe reactive arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7795|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/7/23676\" title=\"table 1\">",
"      Differential dx of arthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25289?source=related_link\">",
"      Arthritis associated with gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=related_link\">",
"      Assessment and treatment of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=related_link\">",
"      Clinical manifestations and diagnosis of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=related_link\">",
"      Clinical manifestations of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=related_link\">",
"      Diagnosis and differential diagnosis of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=related_link\">",
"      Evaluation of the child with back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/14/6377?source=related_link\">",
"      Mechanisms for the induction of rheumatic symptoms by gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/18/4392?source=related_link\">",
"      Musculoskeletal ultrasonography: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/38/19045?source=related_link\">",
"      Patient information: Ankylosing spondylitis and spondyloarthritis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/0/30721?source=related_link\">",
"      Patient information: Reactive arthritis (formerly Reiter syndrome) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=related_link\">",
"      Spondyloarthropathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=related_link\">",
"      Uveitis: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/10/10407?source=related_link\">",
"      Uveitis: Treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_57_9115="Hunt and Hess grading system";
var content_f8_57_9115=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F69179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F69179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hunt and Hess grading system for patients with subarachnoid hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Neurologic status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Asymptomatic or mild headache and slight nuchal rigidity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        Severe headache, stiff neck, no neurologic deficit except cranial nerve palsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Drowsy or confused, mild focal neurologic deficit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        Stuporous, moderate or severe hemiparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        Coma, decerebrate posturing",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Based upon initial neurologic examination; adapted from: Hunt W, Hess R, J Neurosurg 1968; 28:14.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9115=[""].join("\n");
var outline_f8_57_9115=null;
var title_f8_57_9116="Management of unstable aortic dissection";
var content_f8_57_9116=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology guidelines: management of hemodynamically unstable patients with suspected aortic dissection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recommendation",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Class",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Profound hemodynamic instability: intubation and ventilation.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Transesophageal echocardiography as the sole diagnostic procedure; call surgeon.",
"       </td>",
"       <td>",
"        II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Surgery, based on findings of cardiac tamponade by transthoracic echocardiography.",
"       </td>",
"       <td>",
"        II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Pericardiocentesis (lowers intrapericardial pressure, may cause recurrent bleeding).",
"       </td>",
"       <td>",
"        III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"        Classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class I:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class II:",
"        </strong>",
"        Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIa:",
"        </strong>",
"        Weight of evidence/opinion is in favor of usefulness/efficacy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIb:",
"        </strong>",
"        Usefulness/efficacy less well established by evidence/opinion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class III:",
"        </strong>",
"        Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful and in some cases may be harmful.&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data reproduced with permission from Erbel, R, Alfonso, F, Boileau, C, et al, Eur Heart J 2001; 22:1642.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9116=[""].join("\n");
var outline_f8_57_9116=null;
var title_f8_57_9117="Treatment of cellulitis in neonates";
var content_f8_57_9117=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested options for empiric treatment of cellulitis in neonates*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Infants 0 to 4 weeks of age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Infants &lt;1 week of age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Infants &ge;1 week of age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        BW &lt;1200 g",
"       </td>",
"       <td class=\"subtitle2\">",
"        BW 1200 to 2000 g",
"       </td>",
"       <td class=\"subtitle2\">",
"        BW &gt;2000 g",
"       </td>",
"       <td class=\"subtitle2\">",
"        BW 1200 to 2000 g",
"       </td>",
"       <td class=\"subtitle2\">",
"        BW &gt;2000 g",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Empiric parenteral therapy options",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vancomycin",
"        <sup>",
"         &bull;",
"        </sup>",
"        <br/>",
"        <strong>",
"         PLUS either:",
"        </strong>",
"       </td>",
"       <td>",
"        15 mg/kg IV every 24 hours",
"       </td>",
"       <td>",
"        10 to 15 mg/kg IV every 12 or 18 hours",
"       </td>",
"       <td>",
"        10 to 15 mg/kg IV every 8 or 12 hours",
"       </td>",
"       <td>",
"        10 to 15 mg/kg IV every 8 or 12 hours",
"       </td>",
"       <td>",
"        10 to 15 mg/kg IV every 6 or 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cefotaxime",
"       </td>",
"       <td>",
"        50 mg/kg IV every 12 hours",
"       </td>",
"       <td>",
"        50 mg/kg IV every 12 hours",
"       </td>",
"       <td>",
"        50 mg/kg IV every 8 or 12 hours",
"       </td>",
"       <td>",
"        50 mg/kg IV every 8 hours",
"       </td>",
"       <td>",
"        50 mg/kg IV every 6 or 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\" colspan=\"6\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gentamicin",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        2.5 mg/kg IV every 18 to 24 hours",
"       </td>",
"       <td>",
"        2.5 mg/kg IV every 12 hours",
"       </td>",
"       <td>",
"        2.5 mg/kg IV every 12 hours",
"       </td>",
"       <td>",
"        2.5 mg/kg IV every 8 or 12 hours",
"       </td>",
"       <td>",
"        2.5 mg/kg IV every 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Oral therapy options (for completion of therapy when pathogen unknown)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clindamycin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        5 mg/kg orally every 12 hours",
"       </td>",
"       <td>",
"        5 mg/kg orally every 12 hours",
"       </td>",
"       <td>",
"        5 mg/kg orally every 8 hours",
"       </td>",
"       <td>",
"        5 mg/kg orally every 8 hours",
"       </td>",
"       <td>",
"        5 to 7.5 mg/kg orally every 6 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Linezolid",
"       </td>",
"       <td>",
"        10 mg/kg orally every 8 or 12 hours",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        10 mg/kg orally every 8 or 12 hours",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        10 mg/kg orally every 8 or 12 hours",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        10 mg/kg orally every 8 hours",
"       </td>",
"       <td>",
"        10 mg/kg orally every 8 hours",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BW: birth weight; IV: intravenously.",
"     <br/>",
"     * Treatment of cellulitis in neonates usually requires hospitalization and parenteral therapy. Empiric therapy must include coverage for group B",
"     <em>",
"      streptococcus",
"     </em>",
"     in addition to methicillin-resistant",
"     <em>",
"      Staphylococcus aureus",
"     </em>",
"     and other beta-hemolytic streptococci.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Optimal dose should be based on determination of serum concentrations.",
"     <br/>",
"     &Delta; If isolate is susceptible.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Dosing every 12 hours is recommended for infants &lt;34 weeks' gestation and &lt;1 week of age.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: American Academy of Pediatrics. Antibacterial drugs for newborn infants: Dose and frequency of administration. In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.745.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9117=[""].join("\n");
var outline_f8_57_9117=null;
var title_f8_57_9118="ECT consent acute phase";
var content_f8_57_9118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F51881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F51881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Electroconvulsive Therapy (ECT) Consent Form: Acute Phase",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Name of Patient:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       <p>",
"        My doctor, _____________________________________, has recommended that I receive treatment with electroconvulsive therapy (ECT). This treatment, including the risks and benefits that I may experience, has been fully described to me. I give my consent to be treated with ECT.",
"       </p>",
"       <p>",
"        Whether ECT or an alternative treatment, like medication or psychotherapy, is most appropriate for me depends on my prior experience with these treatments, the features of my illness, and other considerations. Why ECT has been recommended for me has been explained.",
"       </p>",
"       <p>",
"        ECT involves a series of treatments that may be given on an inpatient or outpatient basis. To receive each treatment I will come to a specially equipped area in this facility. The treatments are usually given in the morning. Because the treatments involve general anesthesia, I will have had nothing to eat or drink for several hours before each treatment. Before the treatment, a small needle will be placed in my vein so that I can be given medications. An anesthetic medication will be injected that will quickly put me to sleep. I will then be given another medication that will relax my muscles. Because I will be asleep, I will not experience pain or discomfort or remember the procedure. Other medications may also be given depending on my needs.",
"       </p>",
"       <p>",
"        To prepare for the treatment, monitoring sensors will be placed on my head and body. Blood pressure cuffs will be placed on an arm and leg. This monitoring involves no pain or discomfort. After I am asleep, a carefully controlled amount of electricity will be passed between two electrodes that have been placed on my head.",
"       </p>",
"       <p>",
"        I may receive bilateral ECT or unilateral ECT. In bilateral ECT, one electrode is placed on the left side of the head, the other on the right side. In unilateral ECT, both electrodes are placed on the same side of the head, usually the right side. Right unilateral ECT (electrodes on the right side) is likely to produce less memory difficulty than bilateral ECT. However, for some patients bilateral ECT may be a more effective treatment. My doctor will carefully consider the choice of unilateral or bilateral ECT.",
"       </p>",
"       <p>",
"        The electrical current produces a seizure in the brain. The amount of electricity used to produce the seizure will be adjusted to my individual needs, based on the judgment of the ECT physician. The medication used to relax my muscles will greatly soften the contractions in my body that would ordinarily accompany the seizure. I will be given oxygen to breathe. The seizure will last for approximately 1 minute. During the procedure, my heart, blood pressure, and brain waves will be monitored. Within a few minutes, the anesthetic medications will wear off and I will awaken. I will then be observed until it is time to leave the ECT area.",
"       </p>",
"       <p>",
"        The number of treatments that I will receive cannot be known ahead of time. A typical course of ECT is 6 to 12 treatments, but some patients may need fewer and some may need more. Treatments are usually given three times a week, but the frequency of treatment may also vary depending on my needs. If I need more than ________ treatments, my written consent will be reobtained.",
"       </p>",
"       <p>",
"        ECT is expected to improve my illness. However, I understand that I may recover completely, partially, or not at all. After ECT, my symptoms may return. How long I will remain well cannot be known ahead of time. To make the return of symptoms less likely after ECT, I will need additional treatment with medication, psychotherapy, and/or ECT. The treatment I will receive to prevent the return of symptoms will be discussed with me.",
"       </p>",
"       <p>",
"        Like other medical treatments, ECT has risks and side effects. To reduce the risk of complications, I will receive a medical evaluation before starting ECT. The medications I have been taking may be adjusted. However, in spite of precautions, it is possible that I will experience a medical complication. As with any procedure using general anesthesia, there is a remote possibility of death from ECT. The risk of death from ECT is very low, about 1 in 10,000 patients. This rate may be higher in patients with severe medical conditions.",
"       </p>",
"       <p>",
"        ECT very rarely results in serious medical complications, such as heart attack, stroke, respiratory difficulty, or continuous seizure. More often, ECT results in irregularities in heart rate and rhythm. These irregularities are usually mild and short lasting but in rare instances can be life threatening. With modem ECT technique, dental complications are infrequent and bone fractures or dislocations are very rare.",
"       </p>",
"       <p>",
"        If serious side effects occur, I understand that medical care and treatment will be instituted immediately and that facilities to handle emergencies are available. I understand, however, that neither the institution nor the treating physicians are required to provide long-term medical treatment. I shall be responsible for the cost of such treatment whether personally or through medical insurance or other medical coverage. I understand that no compensation will be paid for lost wages or other consequential damages.",
"       </p>",
"       <p>",
"        The minor side effects that are frequent include headache, muscle soreness, and nausea. These side effects usually respond to simple treatment.",
"       </p>",
"       <p>",
"        When I awaken after each treatment, I may be confused. This confusion usually goes away within 1 hour. During the treatment course I may have new difficulties in attention and concentration and other aspects of thinking. These problems rapidly go away after completion of ECT.",
"       </p>",
"       <p>",
"        I understand that memory loss is a common side effect of ECT. The memory loss with ECT has a characteristic pattern, including problems remembering past events and new information. The degree of memory problems is often related to the number and type of treatments given. A smaller number of treatments is likely to produce less memory difficulty than a larger number. Shortly following a treatment, the problems with memory are greatest. As time from treatment increases, memory improves.",
"       </p>",
"       <p>",
"        I may experience difficulties remembering events that happened before and while I received ECT. The spottiness in my memory for past events may extend back to several months before I received ECT, and, less commonly, for longer periods of time, sometimes several years or more. Although many of these memories should return during the first few months following my ECT course, I may be left with some permanent gaps in memory.",
"       </p>",
"       <p>",
"        For a short period following ECT, I may also experience difficulty in remembering new information. This difficulty in forming new memories should be temporary and typically disappears within several weeks following the ECT course.",
"       </p>",
"       <p>",
"        The majority of patients state that the benefits of ECT outweigh the problems with memory. Furthermore, most patients report that their memory is actually improved after ECT. Nonetheless, a minority of patients report problems in memory that remain for months or even years. The reasons for these reported long-lasting impairments are not fully understood. As with any medical treatment, people who receive ECT differ considerably in the extent to which they experience side effects.",
"       </p>",
"       <p>",
"        Because of the possible problems with confusion and memory, I should not make any important personal or business decisions during or immediately after the ECT course. During and shortly after the ECT course, and until discussed with my doctor, I should refrain from driving, transacting business, or other activities for which memory difficulties may be troublesome.",
"       </p>",
"       <p>",
"        The conduct of ECT at this facility is under the direction of Dr. ______________________. I may contact him/her at _______________________ if I have further questions.",
"       </p>",
"       <p>",
"        I am free to ask my doctor or members of the ECT treatment team questions about ECT at this time or at any time during or following the ECT course. My decision to agree to ECT is being made voluntarily, and I may withdraw my consent for further treatment at any time.",
"       </p>",
"       <p>",
"        I have been given a copy of this consent form to keep.",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Signature:",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Date:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"2\">",
"       Person Obtaining Consent:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\">",
"       Name:",
"      </td>",
"      <td class=\"subtitle2_left\">",
"       Signature:",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from the Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Copyright &copy; 2001 American Psychiatric Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9118=[""].join("\n");
var outline_f8_57_9118=null;
var title_f8_57_9119="Actively bleeding GU Endosc";
var content_f8_57_9119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bleeding gastric ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 266px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy shows an actively bleeding gastric ulcer in the lesser curvature.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rome Jutabha, MD and Dennis M Jensen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_57_9119=[""].join("\n");
var outline_f8_57_9119=null;
